Sandeep Agarwal, VP of Acquisitions and BD, Xperi Corporation
Sandeep Agarwal is an IP industry leader with over 30 years’ experience in engineering, consulting and R&D environments. He is currently Vice President of Acquisitions and BD at Xperi Corporation, a NASDAQ company with 5000 patents and $200 million annual revenues through licensing.
Prior to Xperi, Sandeep CEO and President of Clairvolex Inc., an IP services company providing prosecution and monetization expertise to industry, law firms and R&D institutes across the world. Before that he was Vice President of portfolio development at Tessera where he led patent acquisitions, managed the compliance program and royalty forecasting. Sandeep came to Tessera from IP Value Management Inc, where he helped to monetize the IP portfolios of several large, well-known companies.
Sandeep developed a deep understanding of federal and university technology transfer systems during his tenure as VP of sponsored research and licensing at the National Technology Transfer Centre (NTTC) and as senior account executive at the Idaho National Laboratory. Sandeep also managed the business accelerator and helped to launch start-up companies based on laboratory technologies. Earlier in his career, he worked for major international consulting, engineering and original equipment manufacturer companies as an engineer and business development manager.
Sandeep holds an MBA in international management, an MS in industrial engineering and a BS in mechanical engineering. He is a certified licensing professional and is an active member of the Licensing Executives Society and the Association of University Technology Managers (AUTM). He has authored several articles for industry publications, including the chapter “Electronic Management and Tracking Systems” published in AUTM’s Technology Transfer Practice Manual (volume 3), and is a frequent presenter/speaker at conferences. In 2013, he was he was recognized as one of “World’s Top 300 leading IP Strategists” by the IAM magazine.
Kamil Ali-Jackson, Chief Legal Officer and co-founder, Aclaris Therapeutics
Kamil Ali-Jackson, Chief Legal Officer and co-founder of Aclaris Therapeutics. With more than 35 years of experience in the legal and pharmaceutical industries, Kamil also serves as Chief Compliance Officer and Corporate Secretary of Aclaris. Previously, she served as legal counsel and as a licensing business executive for a number of pharmaceutical companies, including Merck & Co. Inc., Dr. Reddy’s Laboratories Inc. and Endo Pharmaceuticals, Inc. More recently, she was featured in the 2020 May issue of the Vanguard Law Magazine.
Paul Ashcraft, Intellectual Property Liaison, Halliburton
Paul Ashcraft is an intellectual property professional most recently having served as an Intellectual Asset Manager with Halliburton, servicing one of the largest patent portfolios in North America. Paul originally entered the Oil and Gas industry as a formulation chemist, and has managed preparation and prosecution for a wide variety of scientific disciplines including chemical compositions, artificial intelligence, and remediation technologies. Paul has passed the patent registration exam and is awaiting a registration number.
Amy Banse, Senior Vice President, Comcast Corporation
Amy Banse has over 27 years of experience investing in, acquiring and building companies at Comcast. As Senior Vice President of Programming Investments from 1996 to 2004, she oversaw the development of Comcast’s cable network portfolio, leading investments in E!, The Golf Channel and the Company’s regional sports networks (now the NBC Sports networks) and launching Sprout (now Universal Kids). She was the founder and president of Comcast’s digital media division, Comcast Interactive Media, from 2004 to 2011, driving the acquisition of a number of digital properties, including Fandango, and, together with her team, overseeing the development of Xfinity TV. Her transition to venture capital came in 2011 when she moved to San Francisco to head up the company’s venture capital arm, Comcast Ventures. Under her leadership, Comcast Ventures has expanded its team and geography to include offices in New York and Los Angeles and has grown the size and diversity of its portfolio, making it one of the country’s most active corporate venture arms. Today Comcast Ventures invests in early and later stage companies across a wide spectrum of categories, including commerce, digital media, cybersecurity, SaaS, enterprise, and autonomous vehicles. In addition to serving on the boards of portfolio companies Nextdoor, TuneIn and Quantifind, Banse also serves on the board of Adobe, The Clorox Company and the nonprofit Tipping Point Community.
Julie Barnes-Wiese, J.D., CLP, Executive Director, GHIAA
Julia Barnes-Weise, J.D., CLP, Executive Director of the Global Healthcare Innovation Alliance Accelerator, co-founded the non-profit GHIAA in the spring of 2116 as a spin out of her work at Duke University as a Visiting Associate Professor of the Practice at Duke’s Sanford School of Public Policy, and Director of the Sanford Innovation, Technology Policy project. The GHIAA MAPGuide, a guide to global health agreements, was launched in August 2020. www.ghiaa.org
She is a lawyer, board member, business development executive and Certified Licensing Professional and has been a member of the Licensing Executive Society since 1986. In October she will become a board member of LES.
Julie has been a Senior Business Development and Legal Consultant to the Coalition for Epidemic Preparedness Innovations (CEPI) for over three years.
She has also been a consultant on partnering for the Pandemic Preparedness Framework initiative of the WHO, during which time she co-authored a paper on the success and failures of the Ebola Outbreak 2014 consortia and created a system for monitoring potential Priority Pathogen development partner matching.
Julie is a Collaborator with the Harvard University’s Berkman Klein Center Global Access in Action initiative.
She is a frequent speaker on healthcare licensing and partnering and was a founding member of the Alliance Management Sector of the Licensing Executive Society.
Julie is also a Consultant and lecturer for the Duke Law School Access to Medicines course; and a Board Member of the Medical University of South Carolina Foundation for Research and Development.
She is a former Director of Business Development at Glaxo Wellcome (now GSK), an attorney at SAS Institute and also founded and has consulted for BioMatch, LLC for many years. She has decades of experience negotiating IP licenses, alliance agreements and advising healthcare companies and institutions on partnering strategies. She has consulted with both US and European start-up companies and initiatives, including developing business development plans for venture capitalist backed spin out companies.
Julie Barnes-Weise has a BA in Economics and Literature from Ohio Wesleyan University, a JD from the University of North Carolina at Chapel Hill, completed a yearlong Notre Dame University Law School program on International Trade, and a course on International Marketing from the Duke University Executive Education program at the Fuqua School of Business.
Jeffrey Bartholomew, Shareholder, Robinson Waters & O’Dorisio, P.C.
Mr. Bartholomew has represented numerous startup and emerging companies in manufacturing, service and technology-driven industries. At Robinson Waters & O’Dorisio, P.C., his clients’ transactions include private and public equity offerings, venture capital financing, mergers and acquisitions, licensing of intellectual property and joint ventures. Jeff is a member of the American, Colorado and Denver Bar Associations and is co-chair of the Denver Chapter of the Licensing Executives Society.
Barbara Bates, Global CEO, Hotwire
Barbara is the Global CEO of Hotwire and the former founder and CEO of Eastwick Communications – which was acquired by Hotwire in 2016. She has more than 25 years’ experience working with brands to tell their stories, accelerate growth and build value working in Silicon Valley and beyond.
Barbara has partnered with some of the world’s biggest technology brands as well as emerging leaders to create high-impact communication strategies and was named in Business Insider’s 2014 list of 50 Best Public Relations People in Tech and one of the Top 5 Women in PR by the PR World Awards.
Barbara has been recognized as one of San Francisco Bay Times’ Most Influential Women In Bay Area Business, one of the honorees of PRWeek’s 2020 Hall of Femme and was awarded an Outstanding Individual Achievement award from PRovoke SABRE Awards in 2020.
Edgar Baum, Founder & CEO, Avasta Inc
Edgar is the founder and CEO of Avasta Incorporated, a company that measures business, especially its customers, brands, and other intellectual capital.
Through Avasta and academic teaching, Edgar leads the development of educational content and commercial practices to measure corporate value drivers and risk in today’s 80%+ intangible economy. His integration of finance, mathematics, market research, and forecasting provides organizations with solid financial rationale for intangible asset and brand investments as well as strengthening legal protections.
Prior to Avasta, Edgar has led organizations in brand economics, brand valuation, financial forecasting and commercial fundraising including Brand Finance, Procter & Gamble, and Merrill Lynch.
In addition to being a key contributor to the Intangible Assets in the Boardroom standard development process at the LES, Edgar also leads the global development of the ISO 20671 standard that enables corporations to measure the financial performance of their brands and customer relationships in a repeatable, transparent manner. He also developed the world’s first graduate course on the discipline of financial brand measurement for the University of Toronto which he continues to teach today.
Edgar lives in Toronto, Canada with his wife and two young children. He’s an active advocate for professional mentoring and leadership programs and has coached or mentored hundreds of students and professionals in the past decade.
Benjamin Beaven, Global Director of Strategic Development, Getty Images
Benjamin has a passion for visual communication and emerging technologies, his focus is on building long term strategic relationships with partners to enable them to scale. He has experience in computer vision and machine learning projects that use imagery and associated meta-data to improve model performance. Partners range from leading technology platforms to start-ups seeking to innovate and disrupt.
Garrard Beeney, Partner, Sullivan & Cromwell LLP
Garrard Beeney, co-head of the Firm’s Intellectual Property and Technology Group, is regularly recognized as a leading lawyer for his counsel to clients on intellectual property and licensing transactions and litigation matters around the world. IAM Patent 1000 lauds Mr. Beeney as “the person to connect with when you want to push the boundaries,” commenting that he is “one of the best in the business” and “a fine litigator with sound judgment and strong pragmatic instincts.” Peers report, “when there is something you can’t do, you send it to him.” Legal 500 reports that Mr. Beeney has unparalleled experience advising on the formation of patent licensing pools.
Mr. Beeney has handled patent and intellectual property matters before the U.S. Supreme Court, the International Trade Commission, the U.S. Patent Trademark Office, federal district and appellate courts, arbitrations in a variety of forums, and regularly advises on non U.S. litigation, particularly in the European Community. He has represented both plaintiffs and defendants in infringement actions and advises plaintiffs on patent selection in pre-suit due diligence. Mr. Beeney has also represented clients before U.S. and European competition law authorities, particularly at the intersection of intellectual property and competition laws.
Beyond litigation, Mr. Beeney’s work includes advising clients on FRAND, patent damages, licensing, monetization, and pool formation and multi-party licensing. He has expertise structuring, drafting and negotiating IP-intensive transactions, including in the context of licensing, joint ventures, monetization, divestitures and other corporate transactions. Mr. Beeney’s licensing experience expands beyond the U.S., including the European Union, Korea, Japan and China.
Clients commend Mr. Beeney for his collaborative approach to matters, as The American Lawyer recently noted, quoting BlackBerry’s counsel: “I don’t think I have ever worked with counsel that have worked as collaboratively on a litigation as big as this. They made it easy for us to be full partners in this endeavor.”
Mr. Beeney is a frequent speaker at IP, antitrust and legal forums and often contributes thought leadership pieces, particularly in the area of standard essential patents and world-wide licensing.
Rocky Berndsen, Head of Patent Analytics, Harrity & Harrity, LLP
Rocky Berndsen is the head of the patent analytics group at Harrity & Harrity. He specializes in providing corporate clients with data analytics that focus on gaining insight and intelligence relating to their patent portfolio, their competitors, their outside counsel, and the patent field in general.
Rocky’s expertise is in providing clients with business-focused data analytics that enables them to make more intelligent decisions regarding portfolio management, competitive intelligence, budgeting, filing strategy, and managing outside counsel. In addition, the data analytics can also be utilized to create powerful presentations for internal teams, as well as, C-level audiences.
Rocky has been in the patent field since 2010, and has nearly two decades of business management experience with a focus on using data analytics to gain insight and add value to organizations.
Bruce Bloom, Chief Collaboration Officer, Healx
Dr. Bruce Bloom is the Chief Collaboration Officer of Healx, Limited, a Cambridge UK based biotech using AI and drug repurposing technology to create new therapies for rare disease patients. Dr. Bloom is the founder and former CEO of Cures Within Reach, a leading global non-profit saving lives by unleashing the untapped potential of human approved drugs, devices, diagnostics and nutraceuticals to quickly deliver safe and affordable treatments and cures for diseases that have no currently effective therapy. Dr. Bloom envisioned and created CureAccelerator®, the only online repurposing research collaboration platform, to bring together clinicians, researchers, funders, and industry to create and conduct proof of concept repurposing clinical trials. Dr. Bloom is an Ashoka Social Entrepreneur Fellow, the Patient Advisory Board Chair for the Institute for Translational Medicine, board member of the Drug Discovery Center and Chair of the Cancer Center Advancement Advisory Boards at the University of Illinois Chicago, member of the Vanderbilt Institute for Clinical and Translational Research External Advisory Board, Executive Board member of Mission: Cure, and is on the Science Advisory Boards of Rediscovery Life Sciences, the Dr. Ralph and Marian Falk Medical Research Trust Awards Programs, the Findacure Fundamental Disease Charity, the Rare Disease Research Hub of the Westchester Biotech Project, OneThree Biotech, and Cures Within Reach for Cancer, and a member of the IRDiRC Working Group on Rare Disease Treatment Access and the editorial board of ASSAY and Drug Development Technologies.
Mihaela Bojin, Associate Director, University of Iowa Research Foundation (UIRF)
Mihaela Bojin is an Associate Director at the University of Iowa Research Foundation (UIRF). She has extensive expertise in intellectual capital management (licensing, business and intellectual property assessment, partnerships) in a variety of areas (pharmaceuticals, drug delivery, medical devices, software, etc.)
Mihaela has held numerous leadership positions as a Board member of the LES Standards Development Organization (SDO), Chair and founder of the LES Iowa Chapter, Chair of the LES Standards ISO/TC 279 Innovation Management Committee, VP of LESI Patent and Technology Licensing Committee, University of Iowa committees (Conflict of Interest, IP policy), and the University of Iowa Staff Council (executive committee, HR, university relations). In 2020, Mihaela was selected as a member of the IAM Strategy 300, an elite global group of IP strategists.
Mihaela is a Certified Licensing Professional (CLP) and a registered patent agent with the U.S. Patent and Trademark Office. Prior to joining UIRF, Mihaela was a patent agent at a New York City Intellectual Property Practice Group, where she managed complex patent dockets for U.S. and foreign pharmaceutical, chemical, and cosmetics clients. Mihaela also has extensive research and teaching experience gained as an assistant professor on tenure track at the City University of New York, and as a postdoctoral scholar at the University of California, Davis, and at New York University. Mihaela holds a PhD in Theoretical Chemistry from Cornell University, and a BSc in Chemistry from University of Bucharest, Romania.
Marc Booth, Chief Intellectual Property Officer, Acacia Research Corporation
Marc Booth is an IP executive with more than 10 years’ experience in patent analysis and licensing in areas including the semiconductor, telecoms, consumer electronics and medical devices fields. He has been instrumental in Acacia Research Group’s acquisition and monetization of hundreds of patent portfolios.
Mr. Booth is currently the Chief IP Officer at Acacia Research Corporation. Prior to this, he was Executive Vice President and General Manager at Acacia from 2013 to 2017. He joined Acacia in 2006 as Vice President of Engineering.
Prior to joining Acacia, Mr. Booth had a career in design and development engineering, which included positions as Director of Engineering at Nicholas Labs, Senior Director of Engineering at Powerwave Technologies, Vice President of Engineering and CTO at Comarco Wireless Technologies and Vice President of Engineering at Sony Corporation’s in-flight entertainment division. He began his engineering career as a master’s fellow at Hughes Aircraft Co Display Systems Division. Mr. Booth holds a BS in Physics from the University of California Riverside and an MSEE from the University of Southern California.
Mr. Booth is a member of the Licensing Executives Society and OCTANe, a Southern California organization dedicated to helping start-up companies find funding and industry support.
Michael Borella, Partner, McDonnell Boehnen Hulbert & Berghoff LLP
Michael S. Borella is a partner with McDonnell Boehnen Hulbert & Berghoff LLP and serves as Chair of the firm’s Software & Business Methods Practice Group. Dr. Borella provides legal and technological advice in support of validity, infringement, patentability analyses, and litigation matters. His expertise includes networking, Internet telephony, wireless communication technologies, telecommunications, financial transactions, cloud computing, routing, TCP/IP, artificial intelligence and machine learning, computer graphics and imaging, voice and facial recognition, robotics, and mobile applications.
James Bowen, Executive Director, Corporate Alliances, University of Pennsylvania
Dr. James Bowen has over 15 years of strategic technology evaluation, partnering and commercialization experience. Jim is the Executive Director of Corporate Alliances at The Penn Center for Innovation and has worked at the University of Pennsylvania for the last 13 years. He and his team are responsible for the negotiation, execution and active ongoing management of complex and impactful strategic alliance programs with both corporate and certain non-profit partners of Penn. Jim and his team have helped pioneer new and innovative translational alliance program deal structures and strategy for Penn that allow for the effective partnering, synergistic co-development, joint governance and rapid translation of new technologies from benchtop discovery into beneficial new products and services. Dr. Bowen and his team have structured and helped to actively manage over a dozen cell therapy and gene therapy technology and product development alliance programs for Penn with many organizations including venture backed start-up companies, biotechs, foundations and multinational corporations.
Dr. Bowen received his Ph.D. in Neurobiology from The University Chicago and B.A. in Biology and Economics from The University of Virginia. He is also a registered U.S. patent agent. Prior to joining Penn, Jim worked in a business development capacity for a biotech company in the Philadelphia area. Jim resides in the Philadelphia area and enjoys running, biking, reading, outdoor adventure and enjoying life with his wife and three children.
Barry Brager, Managing Partner, Perception Partners
Barry, a BFA & MBA by training, has been named an IAM300 World-Leading IP Strategist for the past 12 years. He is a Certified Licensing Professional that specializes in monetization solutions using AI tools & expert knowledge to help IP, R&D and M&A decision-making. Barry is also a co-founder of the Georgia IP Alliance, a non-profit organization helping to build a model IP ecosystem for the benefit of society.
Kevin Brown, Co-Founder, President and CEO, Accencio, LLC
Kevin is the executive leader of Accencio LLC, a technology company dedicated to helping IP owners monetize dormant value in intellectual property.
Kevin received his B.S. in chemistry from West Chester University of Pennsylvania, his J.D. from Widener University School of Law of Delaware, and his M.B.A from Saint Joseph’s University of Philadelphia, Pennsylvania. Kevin began his career in the bio-pharmaceutical industry as a medicinal chemist for ViroPharma Inc. in 2000, and soon thereafter accepted a position with Purdue Pharma L.P. as a research chemist. Kevin’s role with Purdue transitioned in 2008 to support the patent prosecution and competitive intelligence activities of the Discovery Research organization.
In the latter half of 2014, Kevin and other Purdue colleagues created the informatics and analytics driven licensing company SavantIP, where he served as Vice President and General Manager until April 2017. In May of 2017 Accencio was born.
John Carney, Managing Director, China IP Exchange, LLC
John P. Carney is Chairman – Licensing Executive Society International’s – Automotive Industry Advisory Board and Managing Director – China IP Exchange, LLC. John specializes in know-how based IP licensing of industrial product designs and manufacturing processes, with a focus on China based transactions. John’s career in the automotive business spans 40 years, with background in finance, sales, marketing, M&A and program management and led until his retirement, the Licensing team at Delphi/Aptiv. Under John’s direction, the Delphi/Aptiv licensing group completed over 60 licensing and IP related sale transactions.
Albert Wai-Kit Chan, Partner, Law Offices of Albert Wai-Kit Chan, PLLC
Albert Wai-Kit Chan, Ph.D., J.D., is a Patent Attorney with nearly 30 years of legal experience in all aspects of obtaining and litigating patents with a specialty focus on the life sciences. He has prosecuted many biotechnological patents and lectures frequently to industry groups on all aspects of intellectual property. He has been frequently involved in transactional work in China, which includes facilitating joint ventures and contracts. Dr. Chan received his J.D. degree from Columbia University School of Law in New York; his Ph.D. in virology at Baylor College of Medicine in Houston, Texas; and his postdoctoral training at Cold Spring Harbor Laboratory in New York as an American Cancer Society postdoctoral fellow. Born and raised in Hong Kong, he is a graduate of The Chinese University of Hong Kong. He is currently adjunct associate professor in the School of Life Sciences at The Chinese University of Hong Kong and has adjunct professorship in the Department of Health Technology and Informatics at The Hong Kong Polytechnic University. Dr. Chan is founder and director of United States-China Intellectual Property Institute, Inc. (a New York Not-For-Profit Corporation).
Yu-An Chang, Counsel, Hogan Lovells
Yu-An Chang is a counsel in Hogan Lovells Intellectual Property, Media and Technology (IPMT) Practice Group. Yu-An’s practice focuses on advising and counselling multinational companies in all aspects of IP protection as well as licensing and commercialization of IP assets in or relating to China. He has broad experience advising clients on formulation and implementation of strategies to protect and commercialize IP rights. He also regularly assists clients on complex IP transactions and IP aspects of commercial agreements.
Yu-An is a member of the Commercialization of Brands Committee of the International Trademark Association (INTA) and an IP Expert of the China IPR SME Helpdesk funded by the European Commission. He frequently speaks on IP issues at seminars and spoke as a panelist at the LES 2019 Annual Meeting.
Dongmin Chen, Chair Professor, Institute for Advanced Interdisciplinary Studies at Peking University
Dr. Dongmin Chen is a chair professor at the Institute for Advanced Interdisciplinary Studies at Peking University. He is the Executive Director of the Songshan Lake Materials Lab. He was the former Director of the Office of Science and Technology Development at Peking University, which oversees university-industrial partnership, university technology licensing, spin-offs, several incubators and investment funds. Prof. Chen is the International Adviser of WIPO Global Innovation Index. He is also an advisor in innovative economic development of a number of municipal government.
Prof. Chen is a partner advisor of the Light Capital, an early stage venture fund specialized in AI and blockchain technology startups.
Dr. Chen is a serial entrepreneur and has co-founded two silicon-valley-startups,raised more than 100M USD from top VC firms. He co-authored more than 100 scientific publications and 150 US and international patents. Dr. Chen is an Associated Editor for the Journal of Applied Physics.
Tom Chia, Senior Director of Patents & Corporate Development, Via Licensing
Thomas Chia is senior director of patents and corporate development at Via Licensing, a leader in multiparty licensing programs and an independent subsidiary of US technology pioneer Dolby Laboratories. An accomplished intellectual property strategist and attorney, Dr Chia has built a reputation for crafting deals that enable and promote innovation by balancing the needs of manufacturers and innovators around the globe.
He consistently structures IP-centric business deals and other collaborative
arrangements to commercialize some of today’s most valuable technologies, including LTE, 5G, and connected cars.
Dr Chia is a highly regarded expert in standards-based technologies, international multiparty IP programs and fair, reasonable and non-discriminatory licensing, subjects he has published in law reviews and teaches on at top law schools. Throughout his career, he has been instrumental in orchestrating significant IP deals with major technology companies, including Verizon, Alibaba and Toshiba, where his expertise in building bridges with other IP leaders creates significant long-term value for all parties.
Before Via, Dr Chia served at the Ovidian Group, a premier IP and business advisory firm where he represented clients from around the world in developing and executing tailored IP strategies. He also managed worldwide licensing, patent prosecution and strategic patent acquisitions and divestitures for a publicly traded IP licensing company.
Dr Chia received his PhD in engineering from Yale University, where he published in several peer-reviewed scientific publications and served in the university’s tech transfer office. He earned his JD from the University of California, Berkeley School of Law, his BS in engineering from the University of Wisconsin, Madison, and is a registered US patent attorney.
Yu Sarn Chiew, Partner, Yusarn Audrey
Yu Sarn Chiew is a founder and co-managing partner of Yusarn Audrey, a Singapore-headquartered firm of IP strategists, IP lawyers and patent agents with regional offices in Thailand and Malaysia.
Mr Yu Sarn has more than 20 years’ experience in corporate and commercial law and intellectual property, with a specific focus on the commercialisation of intellectual property and the provision of IP-related transactional advice. His practice includes IP licensing, IP acquisitions and sales, IP financing, technology and IP-driven mergers and acquisitions, venture capital and private equity, franchising, media and entertainment, financial technology, digital asset offerings, joint ventures and strategic alliances, R&D agreements, manufacturing, distribution and supply chain management.
Daniel W. Cho, Associate, Covington & Burling LLP
As a litigator, Daniel Cho practices in various areas of intellectual property law, including high-stakes patent and trademark infringement cases, inter partes review proceedings, and trade secret misappropriation cases. He has litigated cases before the United States Court of Appeals for the Federal Circuit, Patent Trial and Appeal Board (PTAB), and district courts throughout the country. Working across numerous technological areas, Mr. Cho has legal experience involving OLED technology, LCD technology, smart phones, touch screen technology, biotechnology, crystallography, pharmaceuticals, medical devices, computer software, casino gaming, oil drilling, and textiles.
As a member of multiple jury and bench trial teams, Mr. Cho plays a key role in all stages of litigation, from managing large trial teams, developing case themes and strategies, drafting and arguing dispositive motions, and preparing trial witnesses. He has also argued motions in several of the nation’s most active patent litigation jurisdictions, and has taken and defended numerous fact and expert witness depositions.
In addition to his trial work, Mr. Cho advises clients on patent validity and infringement, provides freedom-to-operate analyses, and conducts due diligence investigations. He provides strategic advice to clients on developing, obtaining, protecting, managing, and enforcing IP rights in accordance with business objectives.
Mr. Cho also maintains an active pro bono practice.
Before his legal career, Mr. Cho served in the ROK-US Combined Forces Command (CFC). He also worked at the United Nations Commission on International Trade Law (UNCITRAL), where he supported the Secretary of Working Group VI—Security Interests.
Sean Clark, Director of North America IPR & Licensing, Ericsson
Sean is currently the Director of North America IPR and Licensing for Ericsson, Inc. Before joining Ericsson, he was a Senior Director for Intellectual Property at TiVo Corporation. Sean has worked in intellectual property for 20 years at various companies including Lattice Semiconductor, Intellectual Ventures and Microsoft Corporation.
Adrian Cyhan, Partner, Dinsmore & Shohl LLP
Adrian is a registered patent attorney whose practice is focused on identifying, protecting and leveraging intellectual property assets and providing related counsel and advice. He has extensive experience in structuring and negotiating the terms of various types of technology transactions including intellectual property licenses, technology alliances, collaboration and development agreements, outsourced technology development agreements, vendor, supply and other commercial agreements, sponsored research agreements involving industrial entities and universities, non-disclosure and consulting agreements, as well as joint and collaborative R&D agreements involving government entities (CRADAs, funding agreements, etc.).
Adrian’s practice also involves providing strategic counsel to clients in connection with intellectual property portfolio and innovation management, and intellectual property-related issues in the context of transactions such as joint ventures, acquisitions and divestitures. Other areas of expertise include trademark filing and prosecution and related counseling.
He has negotiated hundreds of transactions and prosecuted patents involving representative technologies such as wireless communications, software, green technology and vehicles, social media, mechanical, electrical, and medical device technologies.
Before joining Dinsmore, Adrian practiced with prominent firms in San Diego, Chicago and Detroit.
Prior to earning his J.D., he utilized his materials science engineering background as a design and evaluation engineer at Toyota Technical Center, USA where he developed vehicle components and relationships with component suppliers. He has a B.S. in materials science engineering from the University of Notre Dame and earned his J.D. at the University of Michigan Law School.
John Davis, Partner, Wood, Herron & Evans, L.L.P. (“WH&E”)
John Paul Davis is a Partner with Wood, Herron & Evans, L.L.P. (“WH&E”) and has been practicing intellectual property (“IP”) law for more than nineteen years. Mr. Davis provides counsel on a variety of IP matters including patent, trademark, and copyright prosecution, licensing, and litigation. He represents clients in the U.S. Patent and Trademark Office (“USPTO”), before the Patent Trial and Appeal Board (“PTAB”), and in federal district and appellate courts. Mr. Davis is a member of the firm’s Branding and Content Practice Group, the Mechanical Patent Practice Groups, and is currently the Deputy Practice Group Leader for the firm’s Litigation Practice Group.
Prior to joining WH&E, Mr. Davis served as an Attorney-Advisor for the Air Force Legal Information Services Agency, Maxwell Air Force Base, Alabama and as a Staff Attorney for the United States District Court for the Eastern District of Virginia. Mr. Davis also served in the Air Force Judge Advocate General (“JAG”) Corps Reserve where he retired in the rank of Colonel. As a reservist, he was involved with civil law, military justice, and IP matters, and also provided legal information technology readiness training at the Air Force JAG School, the Army JAG School, and at the Air Force Annual Survey of the Law (“ASOL”).
Joshua P. Davis, Partner, Womble Bond Dickinson
Josh represents stakeholders and defendants in intellectual property matters involving a variety of technologies. Josh has significant experience litigating patent infringement and validity issues in U.S. district court cases and at the U.S. Court of Appeals for the Federal Circuit, as well as at the U.S. Patent and Trademark Office and the U.S. International Trade Commission. Many of Josh’s cases concern pharmaceutical products, biotechnology, or medical devices; and he has also represented companies in high stakes matters involving chemical processes and manufacturing, wireless communication technologies, personal computing, operating and networking systems, semiconductor layout and design, and hardware and software implementations.
Josh participates in all stages of litigation, from initial pre-litigation counseling through case development, trial, and appeal. He has extensive experience in Abbreviated New Drug Application (ANDA) cases, and has represented clients in district courts across the country, including the District of Delaware, District of New Jersey, Eastern District of Texas, and Northern District of California. He also has represented patent holders and challengers in post-grant proceedings before the U.S. Patent and Trademark Office, including inter partes reviews.
Michele DeBlasio, Executive Director, Development & Commercial Alliances, Bristol Myers Squibb
“Bristol Myers Squibb 1995-present
Alliance Management (2010 to present)
Oversee company collaborations, manage cross functional teams, manage and direct governance activities, ensure strategies and decisions are implemented at the appropriate levels, plans and actions are consistent with alliance strategy and in the best interests of the asset
Proactively identify potential issues and conflicts, defines process toward and lead issue consensus and resolution
Creates and manage long term relationships, develop high level of trust within both organizations
·Systems Implementations (2008-2009) BMS Hyperion Budgeting and Projections System and SAP Project System for R&D
·Finance and Reporting (1998-2008) BMS IT and R&D Finance organizations responsible for accounting, close and reporting
Internal Audit (1995-1997) Travel to BMS international sites auditing for risks to specific accounting cycles, such as Revenue, Expenditures, Fixed Assets
Ernst and Young – Senior Auditor 1992-1995″
Jay Kugler DeYoung, Principal, Boston office of Fish & Richardson
Jay Kugler DeYoung, is a Principal in the Boston office of Fish & Richardson. Her practice emphasizes U.S. and foreign patent prosecution, opinion work, and strategic counseling, primarily in biotechnology and other life sciences.
Ms. DeYoung was honored as a “2018 Top Women of Law” by Massachusetts Lawyers Weekly and became recently the new chair of Fish & Richardson’s EMPOWER Women’s initiative.
Pamela Demain, President, Pamela R. Demain Consulting
Since retiring from Merck in late 2016, Pamela has been serving on Boards and leading strategic business development for biotech clients. On Board and VP, Business Development for Prokaryotics, Inc., a start-up biotech in the area of novel antibiotic discovery and Advisor, Business Development for Torreya Partners, a business consulting firm and two additional current clients. On Board at The Institute of Life Sciences Entrepreneurship. Pam is open to learning about available board and consulting opportunities.
Benjamin Dibling, Executive Director of Licensing, Penn Center for Innovation at the University of Pennsylvania
Benjamin Dibling is the Executive Director of Licensing in the Penn Center for Innovation at the University of Pennsylvania, where he leads the licensing and corporate contracting groups. Ben’s team of approximately twenty professional staff are responsible for working with Penn faculty, staff and students to evaluate, protect and commercialize Penn inventions and discoveries, and to facilitate engagement with industry and start-up company formation. Prior to joining Penn in 2016, Ben was Senior Associate Director of Licensing in the Office of Intellectual Property and Industry Sponsored Research at UCLA, where he focused on supporting the commercialization of a wide range of inventions with a focus in life sciences and medicine. Ben started his career in technology transfer in 2004 as a marketing intern at UChicagoTech, the office of technology and intellectual property at the University of Chicago. Ben managed a varied portfolio during his time at UChicagoTech, and was the Program Manager in Oncology at the time he moved to UCLA in 2011.
Ben holds a PhD in Clinical Medicine from the University of Leeds and a BMedSc in Molecular and Cellular Biology from the University of Birmingham. He is licensed to practice before the United States Patents and Trademarks Office.
Robert Dini, Founder, Sisvel
With more than 40 year of experience, Mr. Roberto Dini is one of the best known and appreciated Intellectual Property experts. He began his career with Indesit where he was Head of the Patent and Trademark Office.
In 1982 Mr. Dini founded Sisvel, which has soon become a world leader in managing Intellectual Property and maximizing the value of patent rights. With Sisvel he has developed invaluable experience in setting up and managing patent pools and other forms of IP aggregation. He has extensive expertise in filing and prosecuting patents; drafting contracts for the acquisition or licensing of patents; negotiating with multi-national companies; and assisting patent owners in enforcing their patent rights, especially in the consumer electronics field.
In 1987 Mr. Dini founded Metroconsult, an Intellectual Property consultancy firm with offices in Turin, Milan and Genoa, wherein he transferred the experience acquired from the industrial world, providing his clients with high-quality services “tailored” to the needs of each individual client.
Mr. Dini is a Member of the Italian Industrial Property Consultant Association, a registered Patent Attorney before the European Patent Office (EPO) and Trademark and Design attorney before the European Union Intellectual Property Office (EUIPO). He is member of different IP Associations and past President of LES (Licensing Executives Society) Italy.
Dinesh Divakaran, Director, Digital Innovations, Duke University
Dr. Dinesh Divakaran serves as Director, Digital Innovations with the Office of Licensing & Ventures (OLV) at Duke University and Duke Health. In this role, he leads the commercialization of digital/high tech/emerging tech innovations (software/IT, content and creative works) and data assets from R&D, QI/QA, clinical and innovation activities across Duke Health and Duke University through licenses, ventures, alliances and collaborations.
Outside of his work at Duke, Dr. Divakaran regularly serves as a reviewer/panelist with the SBIR/STTR grant programs at NIH and NSF. A member of the Forbes Business Development Council, he also volunteers as an advisor/mentor/grant reviewer with NC IDEA and sits on the board of advisors of North Carolina Technology Association (NC TECH) and Innovation Committee of Healthcare Information and Management Systems Society (HIMSS).
Dr. Divakaran has also had a short stint in venture capital as a fellow with the Alumni Ventures Group. He joined Duke OLV in late 2015 after having worked as the Associate Director of Technology Transfer at North Carolina State University (NCSU). Prior to working at NCSU, he worked in technology transfer at the Texas A&M University System and the University of South Florida (USF). He also served as an adjunct faculty in electrical engineering at NCSU and USF and collaborated as a co-investigator on research translation projects.
Ben DuPont, Co-Founder and Partner, Chartline Capital Partners
Ben leads the firm’s fundraising, origination, and portfolio support by connecting companies to additional strategic partners, customers, and co-investors. Ben serves as a director of GigSky, Ecrio, Vorbeck, MSCI (NYSE:MSCI), Longwood Gardens, Zip Code Wilmington, and the Tower Hill School.
Ben co-founded yet2 in 1999 and was instrumental to its management buyout; he continues to serve on the board. He also founded yet2Ventures (predecessor to Chartline) in 2010. Previously, Ben worked at the E. I. du Pont de Nemours and Company (DuPont) in multiple businesses including medical products, fibers, specialty chemicals, and engineering.
Ben has a 1986 BSME from Tufts University. He is a licensed pilot, a ham radio operator, and an avid sailor. He lives in Wilmington, Delaware.”
Aaric Eisenstein, VP of Licensing Strategy, Personalized Media Communications
Aaric Eisenstein is Vice President of Licensing Strategy. He is responsible for analyzing markets, identifying opportunities, and negotiating transactions. He has contributed to leading publications about PTAB fairness and other subjects and serves each year as a panelist and/or moderator at various industry conferences. He is the Chair of the LES Patent Licensing Standards Committee.
Before joining PMC in 2012, Aaric held leadership positions in early-stage, technology-driven companies that focused on areas such as food manufacturing, software, and online geopolitical intelligence.
At PMC Aaric works in the following four areas:
- He leads the company’s economic analyses. These include models for licensing rates and pricing structures as well as evaluating new business opportunities.
- He works with other members of PMC’s Licensing Team and has negotiated several licenses in the US and Asia.
- Aaric gives voice to PMC’s thought leadership positions, including on 101, PTAB fairness, and patent quality.
- He has educated Congressional offices on IP issues and the need for legislative fixes to problems in the US patent regime.
Mr. Eisenstein received his BA in Political Economy from Williams College and an MBA from the University of Texas at Austin.
Gillian Fenton, Senior Counsel, Vaccines Legal Operations, GSK Vaccines
Gillian M. Fenton, Esq., CLP has been a member of LES (USA & Canada) since 1992. She has served in a variety of roles, including as member of the LES Insights Editorial Board and later Chair of the Editorial Board; as a volunteer judge and mentor for the LES Foundation International Business Plan Competition, and as Director for Communications and Publications. Gillian is the incoming LES President and Chair of the LES Board for the October 2020 – October 2021 term.
Gillian is presently Senior Counsel at GSK Vaccines, where she is the sole North American attorney for significant vaccines pipeline business development transactions (acquisitions, in-licenses, collaborations, out-licenses, and asset divestments). Gillian’s practice also includes a wide variety of collaborations and R&D funding agreements with U.S. Government entities (NIH/NIAID, BARDA and DARPA). Prior to joining GSK, Gillian was VP, Associate General Counsel & Chief Intellectual Property Counsel at Emergent BioSolutions Inc., where she founded the IP department and oversaw all IP activities in support of Emergent’s IPO and subsequent growth through M&A. Prior to joining Emergent, while in-house patent counsel at Biogen Inc., Gillian led all IP activities in support of market launch of a new biotherapeutic product and secured a favorable outcome in a precedential patent interference proceeding.
Education: J.D. cum laude, Suffolk University Law School; B.Sc. Biochemistry, Trinity College.
Admissions: MA, MD, DC. Registered U.S. Patent Attorney.
Mary Filippelli, Independent Board Member, Corporate Director
Mary is a highly experienced business executive, known for her transformative impact across multiple national and global organizations. A trusted advisor to CEOs and Boards of Directors, Mary combines her understanding of Big S strategy, operations, governance, risk, regulation and financial performance to her Board participation and advisory services. Mary has led the strategy development and execution of dozens of new business models for financial institutions and other enterprises, working closely with regulators and key stakeholders to generate high growth.
Mary is a Chartered Professional Accountant, an Expert Witness and Investigator for CPA Ontario for professional conduct matters. She co-authored the CICA/CPA In-Depth Broker Dealer Book and Course the industry standard and pre-requisite for all auditors. She also published: Balancing Detail & Perspectives, the Fifth Line of Defense to support boards elevate their governance. Mary is a Corporate Board member of Canadian Western Bank and Princess Margaret Cancer Foundation. She serves on the Dean’s Advisory for the Ted Rogers School of Management and has served on the Advisory Board for the Forward Institute in the United Kingdom.
Amy Finan, CEO, Sabin Vaccine Institute
Amy Finan joined the Sabin Vaccine Institute as Chief Executive Officer in April 2016. In her time as CEO, Amy has led the development and implementation of a new organizational strategy focusing Sabin on a mission to make vaccines more accessible, enable vaccine innovation and expand immunization across the globe. Under Amy’s leadership, Sabin has rebuilt its vaccine research & development and global immunization programs, while diversifying and expanding its funder base, reinvigorating the Sabin brand and growing its Board of Trustees and staff.
Prior to joining Sabin, Amy served as senior vice president responsible for business development at the Biotechnology Innovation Organization (BIO). For two years and simultaneous with her BIO responsibilities, she also served as president of the Biotechnology Institute, an organization founded by BIO to promote life science education. Prior to her eleven years with BIO, Amy led corporate communications and investor relations for the former clinical-stage biotechnology company EntreMed, Inc., created and implemented a biotech initiative for Montgomery County, Maryland, and served as a government relations director at the National Association for Biomedical Research. Amy studied at the London School of Economics & Political Science and graduated with a bachelor’s degree in political science from Trinity College in Washington, D.C.
Michael Fisher, Counsel, Dechert LLP
Michael A. Fisher, Ph.D. draws on his extensive background in electrical engineering to represent medical device, electronics, computer, and semiconductor companies in complex patent and trade secret litigation matters. He also devotes part of his practice to patent licensing, patent counseling, and software copyright matters.
Prior to his legal career, Dr. Fisher worked as a research and development engineer in the areas of solid state electronics, equipment-control software, and microelectromechanical systems (MEMS). He is a named inventor on three U.S. patents, relating to a dental instrument, an infrared imager, and a flat-panel computer display (U.S. Pat. Nos. 10,201,398, 5,929,440, and 5,956,003).
Matthew Fitzpatrick, Vice President - Associate General Counsel & Deputy Chief Patent Counsel, The Procter & Gamble Co.
Matthew Fitzpatrick is currently Vice-President & Associate General Counsel – Health Care & Deupty Chief Patent Counsel for The Procter & Gamble Company and is based in Cincinnati, Ohio. He has worked in the legal department at P&G since 1996 in various roles starting as intellectual property counsel focusing on patent practice in P&G’s feminine care and baby care businesses. In 2006 he was appointed Associate General Counsel for P&G’s Norh American baby care business with responsibility for intellectual property, advertising, and other commerical law matters. Between 2008 and 2012 Matt lived in Kobe, Japan with his family and was responsible for P&G’s intellectual property department and operations throughout Asia.
Prior to joining P&G, Matt was a nuclear safety analysis and licensing engineer at the Clavert Cliffs Nuclear Power Plant in southern Maryland. He received a B.S. in Nuclear Engineering from the University of Virginia and a J.D. from the University of Maryland School of Law. He is a member of the Ohio Bar, is registered to practice before the U.S. Patent and Trademark Office, and the U.S. Court of Appeals for the Federal Circuit.
Justin Fogarty, Founder & Managing Director, STS Agility
STS Agility is a leading global provider of financial consulting, business restructuring, debt management, and exit strategy service
Justin has been a senior partner and leader at some of Canada’s most prestigious national and international law firms and is recognized as one of Canada‘s leading lawyers specializing in fraud litigation restructuring and corporate governance. He has been a partner in an M&A firm in London, UK, and has been a founder of two funds in the sub-debt and distressed industries.
He is the author of the Canadian chapter in International Insolvency: Jurisdictional Comparisons (J. William Boone, Ed.) and in Debt Restructuring: An Alternative to Insolvency Proceedings, European Lawyer Reference. Past Vice chair international Bar Association insolvency Restructuring Committee Past Board Member of the Canadian Bar Association
Justin is an Honorary Colonel with the Canadian Forces and was a Commissioner of the Ontario Racing Commission to help restructure and to merge the Commission into the Ontario Lottery and Gaming Commission.
Javeed Froozan, Vice President, Research Business Development & Strategic Alliances, The Leukemia & Lymphoma Society
Javeed Froozan leads the business, alliance, and portfolio management activities in support of the LLS Therapy Acceleration Program® (LLS TAP) venture philanthropy initiative, Grant programs, and other Mission focused initiatives.
Javeed has worked with LLS executives and Board members to generate clinical and economic value and manage risks for LLS, its partners by repositioning LLS TAP into equity investing, and strengthening LLS agreements, corporate structure, processes, and policies.
LLS funding transactions include convertible note, equity, research funding, and revenue share agreements with private and public companies, and research institutions developing novel therapeutics, diagnostics, and digital health services. Notable transactions include the LLS investment in Forty Seven Corporation to support Magrolimab which recently obtained FDA Break-Through Designation after Gilead acquired the company, and generated a 10x ROI to LLS within 1 year from the investment.
Javeed’s corporate development experience spans over 25 years in early stage, growth, and large biopharmaceutical and health technology firms. This includes acquiring over $150 Million worth of companies, products and technologies, enabling two IPO’s in excess of $50 million each, strategic sales and funding of projects worth millions of dollars to develop and launch new products. His experience also includes fostering investment and job creation with acquisitions of what is now a BARDA public-private Center of Innovation Advance Development and Manufacturing, and R&D and headquarters facilities using state and local economic incentives.
Prior to LLS, Javeed was at Emergent BioSolutions in its 10x revenue and market cap growth phase from 2003-2015 including leading the acquisition of Trubion Pharmaceuticals. He managed Emergent’s alliance with Pfizer to develop oncology and auto-immune therapeutic candidates, and to develop NuThraxTM, a novel, anthrax vaccine adjuvanted with CPG-7909.
Javeed previously provided consulting services to Baxter Healthcare on its cell therapy business focused on CD34+ cells to treat vascular ischemia’s, benchmarked technology transfer and venture creation, provided pro-bono guidance to entrepreneurs and scientists, and advised local governments on economic planning for the Life Sciences industry.
Javeed has a B.S. in biology and M.B.A. in economics and finance from The University of Michigan.
Pamela Fulmer, Partner, Tactical Law Group LLP
Pam Fulmer has substantial experience litigating all types of intellectual property and commercial disputes with a special emphasis on licensing disputes. In addition to her litigation practice, Pam devotes a significant portion of her time to defending companies of all sizes in software audits brought by software publishers known for their aggressive audit tactics such as Oracle, Quest, Micro Focus and others.
Her cases have included copyright, trademark, trade secret and patent infringement, as well as privacy related lawsuits. Pam also has experience in lawsuits involving the Lanham Act and false advertising, unfair competition, trade libel, licensing, and other complex litigation.
In addition to her intellectual property practice, Pam has deep experience representing technology and other clients in high-stakes commercial litigation. This litigation has included breach of contract cases as well as lawsuits raising claims of misrepresentation, breach of fiduciary duty, breach of the implied covenant of good faith and fair dealing and other business torts. Pam has been a partner at some of the largest and most prestigious international law firms in the world including Jones Day, DLA Piper and Dentons. She co-founded Tactical Law Group LLP in 2016 after 24 years of big law firm practice.
In her spare time Pam enjoys hanging out with her 4 Havanese dogs, hiking the open space, cooking all types of cuisine, reading historical novels and blogging about the software industry and licensing
Stephen Gardner, Partner, Quarles & Brady LLP
Steve Gardner practices in the firm’s Intellectual Property Group, focusing on IP-related transactions and litigation. He works with both national and start-up companies, as well as research institutions and other IP owners to promote their technology through licensing and collaborative agreements and to maximize commercial value of their developments. When commercialization of IP assets is jeopardized through infringement, or IP agreements are breached, Mr. Gardner assists clients in a variety of enforcement efforts, including proceedings before numerous U.S. district courts and the U.S. Patent and Trademark Office. Mr. Gardner has counseled clients concerning all types of intellectual property in a wide variety of technologies, including on matters relating to software, magnetic resonance imaging, CT imaging, medical devices, industrial equipment, photolithography equipment, semiconductor chip manufacturing methods, liquid crystal display devices, LED manufacturing, and processors and electronic controllers. Prior to joining the firm, Mr. Gardner served for two years as a law clerk for the Hon. Edward J. Damich, Chief Judge of the U.S. Court of Federal Claims, a unique court that has nationwide jurisdiction over various federal government contract and IP disputes. Following his clerkship, he worked as an associate in the Washington D.C. office of a large general practice firm, where he focused on IP protection and enforcement.
Kate Gaudry, Partner, Kilpatrick Townsend
Kate Gaudry is a partner at in the Washington, D.C., office of Kilpatrick Townsend & Stockton LLP. Kate focuses her practice on data-driven and strategic patent prosecution. She has authored over sixty publications sharing results of generally applicable analyses, and her work was also pivotal in the shutting down of the USPTO’s SAWS program, which secretly subjected select patent applications to increased examination scrutiny. Her research and data focus was recognized when she was one of five attorneys across all practice areas to be selected for LexMachina’s and Law360’s Data-Driven Lawyer award in its inaugural year of 2018 and for the National Law Journal’s DC TrailBlaizer award in its inaugural year of 2020.
Most of her clients are in the software, computers, and quantitative-biology technical areas. She particularly enjoys patent-prosecution relating to artificial-intelligence and computational-biology technologies.
Kate holds a J.D. from Harvard Law, a Ph.D. in computational neurobiology from UCSD, and a B.S. in Physics from Fort Hays State University.
Fabian Gonell, Senior Vice President, Licensing Strategy and Legal Counsel, Qualcomm’s
Fabian Gonell is Senior Vice President, Licensing Strategy and Legal Counsel of Qualcomm’s Technology Licensing division, where his responsibilities include developing the Company’s licensing strategy, negotiating license agreements, and overseeing the company’s compliance with the rules of standards organizations. He has played a major role in structuring and negotiating license agreements with many of Qualcomm’s licensees, including Apple, Samsung, LGE, Ericsson, and Nokia/Microsoft, as well as in Qualcomm’s response to regulatory investigations of Qualcomm’s licensing practices.
Prior to joining Qualcomm, Mr. Gonell was a litigator at Cravath, Swaine & Moore LLP in New York, where he represented Qualcomm and other clients in patent and antitrust litigation. He also served as an adjunct professor at the Fordham University School of Law, where he taught courses in interviewing, counseling and negotiation. Mr. Gonell holds a BA in Economics from the City University of New York and a JD from the Fordham University School of Law, where he was Editor-in-Chief of the Fordham Law Review.
Marcos Gonzales Harsha, Principal Deputy Director, Office of Technology Transitions, U.S. Department of Energy
Marcos serves as the Principal Deputy Director at the U.S. Department of Energy’s Office of Technology Transitions. In conjunction with the Director, Marcos works with program offices within DOE as well as with the National Labs to identify and increase awareness of partnership opportunities for the private sector to access and leverage DOE’s portfolio of pioneering R&D, leading scientists and experts, and world-class facilities.
Prior to joining the Office of Technology Transitions in November 2017, he served in roles of increasing responsibility in the Office of the Under Secretary for Science and Energy (now Under Secretary for Science), starting in 2013 as a budget advisor and departing as the Deputy Chief of Staff. During his time with the Under Secretary’s Office, Marcos led an effort to stand up six interdisciplinary crosscutting teams covering topics ranging from the energy-water nexus to grid modernization with a budget footprint of nearly $1 billion of DOE’s R&D portfolio. In his capacity with the Under Secretary, Marcos also helped to stand up both the Office of Technology Transitions and the Energy Investor Center. Marcos has also served as a voting member of the Project Review Committee tasked with reviewing all new loan guarantees recommended for approval by the DOE Loan Programs Office.
Over the course of his career, Marcos has worked in microfinance in Peru and Bolivia, served as an energy and trade analyst with the Council of the Americas in New York City, and survived a bout of the entrepreneurial bug while living in Lima, Peru for a year. He also spent some time in the mortgage finance industry in 2008.
Marcos holds a bachelor’s degree in economics from Princeton University and a master’s degree in international affairs with a focus on international finance from The Fletcher School at Tufts University.
Patrick Govang, Director, Innovation Partnerships, Cornell University
“Patrick is a member of the leadership team at the Center for Technology Licensing and manages the Innovation Partnerships program. His role spans overseeing Cornell’s startup portfolio, corporate research collaborations and he leads CTL’s brand, marketing, and event activity. He serves as a member of the Advisory Board of the Ithaca College School of Business, a past member of the board of the Licensing Executives Society Foundation, and holds board seats or advisory roles with numerous start-up companies. He is a member of Business Forward, an independent research and education organization that takes a business-minded look at policy issues affecting America’s economic competitiveness.
In 2006, Pat co-founded venture-backed start-up, e2e Materials, based on technology licensed from Cornell, where he raised over $12M in grants, loans, and venture capital. e2e was sold in 2018. He has served as the Chairman of Comet Skateboards introducing ground-breaking, triple-bottom-line innovations to the action sports industry. In 2000 he founded Project Point, an online product development and project management tool focused on automotive tier 1 suppliers and OEM manufacturers.
Prior to e2e, Pat worked as the Industrial Partnerships Director at the Cornell Center for Materials Research where he facilitated start-ups and technology transfer. Pat started his career in the automotive industry working for Mercedes-Benz, The Dana Corporation, and Deloitte Consulting. He studied product development and design at Bowling Green State University and holds a number of patents.
Rob Guay, Senior Counsel, Intellectual Property, Shopify Inc.
Rob leads the patent development efforts at Shopify, including purchasing patents. He has had in-house IP positions at Huawei, Ericsson, Blackberry and Bombardier. Rob graduated from both law school and electrical engineering from the University of Ottawa.
Michele Gunness, Senior Technology Development Manager, Oregon Health & Science University
Michele is currently a Senior Technology Development Manager and has been with OHSU Technology Transfer for over 15 years. Michele is a member of the Licensing group and responsible for evaluating new invention disclosures, identifying commercial opportunities, and negotiating license agreements.
Prior to her career in university Technology Transfer, Michele was an Assistant Professor at the University of Connecticut Health Center, a Research Scientist at the Portland Veterans Affairs Medical Center, Pathology and Laboratory Medicine Service, and an Assistant Professor in the Department of Pathology at OHSU. Michele achieved “”Certified Licensing Professional”” certification from the Licensing Executives Society (LES) in November 2014. She is a member of the Licensing Executives Society, past Chair for the Oregon/SW Washington LES Chapter, Association of University Technology Managers and the Oregon Bioscience Association.
Michele received a Bachelor’s degree from Franklin Pierce University in Rindge, NH, a Ph.D. from the University of Connecticut, and was the recipient of a National Research Service Award Post-Doctoral Fellowship at the University of Connecticut Health Center.
Thomas Axel Haag, Ph.D., J.D., Managing Partner, Haag Life Sciences Law
Thomas Haag, Ph.D. is a biotechnology IP lawyer, investor and entrepreneur. He is founder of Haag Life Sciences Law and a Managing Member of Linden Lake Venture Capital. He has a 20-year background in biotech IP and served as partner and co-Chair of Seyfarth Shaw LLP’s Life Sciences IP Practice. Prior to its acquisition by Seyfarth in 2016, he was Chair of Fanelli Haag PLLC a preeminent life sciences focused D.C. law firm he co-founded in 2009. He was also a co-founder, and Interim CEO of PhosImmune, Inc., an immuno-oncology company formed in 2012 and acquired by Agenus, Inc. (NASDAQ: AGEN) in 2015.
Susan Hallen, IP Management Solutions Lead, IBM
Ms. Hallen is a Sales and Delivery Associate Partner in the AI Workflows team. She focuses on bringing repeatable AI assets to market including IP Advisor with Watson, Outside Counsel Insights, and Clarity360. She manages design and implementation of Intellectual Property processes and tools, leveraging the IP Management solutions suite of consulting services. She also leads teams of consultants in IP transformation and business transformation internationally.
Her expertise ranges from Innovation/Product Development to Geographic Information Systems to Intellectual Property across multiple industries.
Ms. Hallen has a broad 40+ year background based in engineering and design, and for the past 10 years focused on IP Licensing and Management. She is a member of the IBM Industry Academy. She holds a Bachelor of Science degree in Structural (Civil) Engineering and a Masters in Business Administration in addition to being a Licensed Professional Engineer in the United States.
Chris Hannon, Patent Attorney, USPTO
Mr. Hannon is a Patent Attorney with the United States Patent and Trademark Office’s Office of Policy and International Affairs (OPIA). Mr. Hannon’s portfolio encompasses standard-essential patent issues, patent subject matter eligibility issues, policy issues relating to artificial intelligence, and policy issues relating to plant inventions.
Mr. Hannon received his Juris Doctorate from George Mason University in Arlington, Virginia. Mr. Hannon holds undergraduate degrees in electrical engineering and computer engineering from North Carolina State University in Raleigh, North Carolina, in addition to an undergraduate degree in computer science from Elon University in Elon, North Carolina. Mr. Hannon is an adjunct professor at George Mason’s Antonin Scalia Law School.
Peter Harter, Founder, The Farrington Group
Peter Harter bridges the ecosystems of technology, policy, business, law, politics, and entrepreneurship. As the Founder of The Farrington Group, a privately held consulting firm, Peter provides advice to management, boards and investors on political, legislative, and regulatory risk. Areas of focus are patents, cybersecurity, data, and precision agriculture. Peter co-founded Markup.Law to modernize the workflows of lawmaking. Markup harnesses AI, machine learning, natural language processing and other data techniques to automate the analysis, comparison, and collaborative composition of laws and regulations. Peter is a board member of the Open Source Election Technology (OSET) Institute, a Palo Alto, California based non-profit working with election officials globally on the specifications and code for a new election administration and voting technology framework. Peter’s career began in 1993 as an Internet lawyer in his home town of Bethlehem, Pennsylvania and broadened in Silicon Valley as head of global government affairs for Netscape and EMusic.com and in business development and sales for Securify (McAfee), investors, and startups. He deepened in Washington, DC, lobbying on patent reform for Intellectual Ventures. Peter is a graduate of Lehigh University and Villanova University School of Law. Peter’s wife Shelby is a grape grower and winemaker in the Eola-Amity AVA of the Willamette Valley of Oregon.
Helen Henderson, UK and European Patent Attorney, Withers and Rogers LLP
Helen is a UK and European Patent Attorney with extensive experience of drafting, filing and managing international patent portfolios for a range of UK and overseas clients, with a focus on the UK and US Higher Education sectors and start-ups.
With a background in neuroscience, Helen has a particular interest in biotechnology patents, working with inventions encompassing molecular biology, cell culture, regenerative medicine, antibodies, gene therapies, cancer immunology, generation and use of recombinant proteins, and genome engineering.
Kevin Higgins, Group Lead Outlicensing, Worldwide Business Development, Pfizer
Kevin is currently Group Lead Outlicensing in Worldwide Business Development for Pfizer and is based in Collegeville, PA. He joined Pfizer in 2009 when Pfizer acquired
At Wyeth Kevin held a variety of positions of increasing responsibility in business development and marketing. Prior to joining the BD group, he was in managed care marketing and represented this department on the Protonix launch team, as well as supporting the marketing of other key brands to MCOs and long-term care organizations.
Prior to joining Wyeth Kevin worked at Bristol-Myers Squibb in managed care marketing and operations, product marketing for a hospital based product, and finance.
Linda Hogan, President and Founder, LLH Associates
Held roles as advisor, business development executive, executive leadership team member, and board director for several early-, mid-, and late-stage VC-backed biopharma companies. Guided business and transaction strategy, capital raising, product positioning and commercial support, acquisition and licensing deals, and executive succession planning.
Kimberly Honeycutt, PhD, Assistant General Counsel - Intellectual Property, Elanco Animal Health
Kimberly Honeycutt is Assistant General Counsel at Elanco Animal Health, where Kimberly helps manage the team responsible for the global Intellectual property portfolio. In this role, her responsibilities include management of Elanco’s patent portfolio, including procurement, enforcement and defense of global patent rights; provision of legal counsel related to all aspects of Elanco’s business concerning intellectual property rights, such as freedom operate and exclusivity strategies; and management of licensing relationships with third parties. Prior to joining Elanco, Dr. Honeycutt practiced as an in-house patent counsel for Bayer Healthcare and as a private attorney at Polsinelli. She has experience in global patent portfolio and exclusivity creation, product life-cycle planning, transactional work, and international patent procurement and enforcement. Dr. Honeycutt earned her Ph.D. in molecular and cellular biology from Baylor College of Medicine and received her J.D. from Washburn University School of Law. Kimberly enjoys exploring the outdoors and planning for the next adventure with the husband and kids.
Junaid Islam, Cybersecurity Expert, National Spectrum Consortium
Junaid Islam is a cybersecurity expert with 30 years of experience in secure communications. His background spans field operations to the design and development of protocols. Junaid’s technical contributions have been incorporated into a broad range of commercial and government networks. Junaid’s achievements include Frame Relay QoS to enable MLPP at the US DoD and MPLS buffer management in the 90s and Mobile IPv6 for Netcentric Warfare in 2004. Currently Junaid is leading the development of Zero Trust security for 5G networks using the Software Definer Perimeter (SDP) protocol. Junaid is a member of OODA which is an organization of technology experts who have supported US national security missions. Junaid is also a Research Fellow at the Cloud Security Alliance which is the industry’s largest trade organization. Junaid was recently appointed to the National Spectrum Consortium (NSC) to lead 5G Security.
Nishant Jaiswal, Senior Counsel | IP Licensing, Hewlett Packard Enterprise
Nishant Jaiswal is Senior Counsel and part of IP Licensing at Hewlett Packard Enterprise. In his role he is responsible for outbound IP transactions at HPE. This includes identifying and closing complex patent divesture and licensing deals, software licensing and source code divesture, administering HPE’s patent pool engagements, providing IP counseling to HPE business units, and supporting HPE M&A and corporate development groups in transactions involving HPE IP Rights.
Nishant has over 15 years’ experience covering various areas of IP, including portfolio management, patent drafting/prosecution, patent acquisition, IP licensing and litigation for clients that include F100 corporations, NPEs, law firms and IP investment funds. He has worked in India and the United States, and has a deep industry and IP knowledge of both countries.
Nishant is registered to practice in California and the US Patent and Trademark Office.
L. Norwood (Woody) Jameson, Partner, Duane Morris
Louis Norwood (Woody) Jameson is chair of Duane Morris’ Intellectual Property Practice Group. Mr. Jameson practices in the area of intellectual property law and litigation with particular emphasis on patent litigation. Mr. Jameson also litigates a broad range of intellectual property disputes, including trademark and trade dress litigation, copyright litigation and false advertising disputes. In 2014, Mr. Jameson was named Outstanding IP Litigator for Georgia, by Managing Intellectual Property. The team he leads also received the Managing Intellectual Property Award for the top patent litigation practice in the southern United States. Mr. Jameson has been named on multiple occasions a Georgia Super Lawyer in the field of IP litigation by Atlanta Magazine and Georgia Super Lawyers Magazine, and, in 2009 through 2019, Chambers USA: America’s Leading Lawyers for Business included Mr. Jameson in its listing of leading IP lawyers in Georgia. Mr. Jameson has represented several well-known companies in complex patent litigation involving such technologies as fiber optics communications, cyber security technology, semiconductors, cable television technology, Internet technology, online banking transactions, MPEG decoding technology, telecommunications and computer hardware and software applications. He likewise has had lead responsibility for trademark and false advertising litigation for Fortune 500 companies, and anti-counterfeiting activities surrounding the 1996 Summer Olympic Games. He is a member of the Litigation and Patent, Copyright and Trademark Law sections of the American Bar Association, the State Bar of Georgia and the Atlanta Bar Association. He has served on the Federal Trial Practice and Procedure Committee of the American Bar Association, has served on numerous committees of the International Trademark Association, and has been a speaker at seminars on a multitude of patent and trademark topics. Mr. Jameson is a 1988 magna cum laude graduate of the University of Georgia School of Law and a 1984 graduate of the University of North Carolina.
Natasha Jones, Commercialization Manager, University of Kentucky
Natasha Jones, MS, JD, MSLS, CLP
Natasha has been a licensing professional at the University of Kentucky since 2011 and is responsible for licensing and market analysis for a diverse technology portfolio, including both physical and life sciences, especially agricultural and veterinary technologies. Prior to 2011, she was a commercialization specialist in UK’s Von Allmen Center for Entrepreneurship (VACE), where she advised startup companies. Natasha wrote the Von Allmen Center’s winning grant application to the Economic Development Administration (EDA) to promote high-wage job creation through high-tech jobs in Kentucky, as well as a winning application for the EDA’s 2010 Innovation in Economic Development Award for Innovation in Commercialization. After majoring in biology at Centre College, Natasha earned a Master of Science in biology at the University of Virginia. Her thesis examined the role of a complete loss-of-function female sterility gene in Drosophila oogenesis. Before graduating from the University of Kentucky (UK) College of Law, Natasha researched the cell-to-cell spread of HSV-1 in UK’s College of Medicine. Natasha is active in the licensing profession, currently servicing as Co-Chair of the Certified Licensing Professional Exam Development & Maintenance Committee.
Carl June, Professor, University of Pennsylvania
Carl June, M.D., is recognized in the oncology field for his groundbreaking work in the development and commercialization of gene therapy and T-cell therapies, including collaboration with Novartis AG on the first FDA approved CAR-T therapy Kymriah. Dr. June has published more than 500 manuscripts on immunotherapy. He currently serves as the Richard W. Vague Professor in immunotherapy in the Department of Pathology and Laboratory Medicine and as the Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine, as well as the Director of the Parker Institute for Cancer Immunotherapy at the University of Pennsylvania. He is the recipient of numerous awards and honors, including his election into the National Academies of Medicine and Science and the American Academy of Arts and Sciences. In 2018, Dr. June was named one of Time Magazine’s 100 Most Influential People for his work in the oncology field. Dr. June graduated from the U.S. Naval Academy and earned his medical degree from the Baylor College of Medicine. He also completed training in immunology and malaria at the World Health Organization and completed his postdoctoral training in transplantation biology with the late Nobel Prize winner Dr. E. Donnall Thomas at the Fred Hutchinson Cancer Research Center.
Stephen Kabakoff, Partner, Miller & Martin
Stephen helps clients with complex issues relating to intellectual property, including strategic portfolio development, preparation and prosecution, licensing, and litigation. His practice primarily focuses on electrical, computer, mechanical, and materials science technologies. In addition to his practice before the U.S. Patent and Trademark Office (USPTO), Stephen has litigated in federal district courts and before the International Trade Commission (ITC) and the Patent Trial and Appeal Board (PTAB) of the USPTO.
Dina Kallay, Head of Antitrust (IPR, Americas & Asia-Pacific), Ericsson
A global antitrust lawyer, with unique international antitrust experience, including agency experience from both the U.S. (FTC) and E.U (DG COMP) and extensive work on Asia-Pacific competition issues. Demonstrated history of working in the information technology and services industry. Strong expertise in competition issues involving intellectual property. Multiple leadership positions in the antitrust world.
Efrat Kasznik, President, Foresight Valuation Group
Efrat Kasznik is President of Foresight Valuation Group and a Lecturer at the Stanford Graduate School of Business. Efrat is a Silicon-Valley based IP valuation and strategy expert with two decades of consulting experience, focusing on assisting IP holders across industries with the valuation, commercialization, and monetization of their intangible assets. She helps clients, ranging in size from Fortune 100 companies to start-ups, with IP and business valuations in support of licensing deals, IP and technology acquisitions, M&A transactions, financial reporting, strategic planning, and fundraising. She frequently serves as a testifying expert in disputes involving IP and startup valuations and damages. Efrat served as Chair of the High-Tech Sector – LES USA-Canada, and is currently on the Board of the LES Silicon Valley Chapter. She has been recognized as one of the top IP strategists in the world by IAM every year since 2013.
Scott Khan, Chief Information + Privacy Officer, LunaDNA
Scott Kahn, PhD. is the Chief Information and Privacy Officer at LunaPBC, a private investor-owned company founded in November 2017. The public benefit corporation is chartered to drive societal value through the aggregation and organization of genomic and health data at a scale and diversity rich enough to solve today’s greatest health challenges. LunaPBC founded LunaDNA, the world’s first community-owned health database that offers shares of ownership to health data contributors. Scott is integrating data privacy and security provisions that comply with GDPR and HIPAA at LunaDNA. Scott is also on the Board of Directors at Rady Children’s Institute for Genomic Medicine and was the former Chief Information Officer and Vice President Commercial, Enterprise Informatics at Illumina.
Sara Kilian, Vice President and General Counsel, Perforce
Sara Kilian is the Vice President and General Counsel at Perforce Software, Inc., a private equity backed company headquartered in Minneapolis, Minnesota. Sara has over 15 years of legal experience working with technology and software companies, including 11 years in private practice as a shareholder at Fredrikson & Byron, P.A., and four years in-house at Perforce.
Kyle Kimble, VP of Business Development and Licensing, Inceptor Bio, LLC
Kyle Kimble is an attorney focused on pharmaceutical and intellectual property law. His PhD in Analytical Chemistry was earned from the University of Pittsburgh developing novel polymeric sensors. His JD was earned from the Robert H. McKinney School of Law: Indiana University where he studied international business law and intellectual property. After several years practicing as a patent attorney with Barnes & Thornburg, a large national general practice firm, Kyle joined the Roche Group and served as patent counsel for their oncology diagnostics business. He next served as lead U.S. patent and intellectual property counsel for Merz Pharmaceuticals, a private specialty pharmaceuticals and aesthetics company. He subsequently joined Know Bio LLC, a private technology incubator focused on developing nitric oxide based therapeutics and devices. Kyle joined Inceptor Bio in 2020 as the VP of Business Development and Licensing where the team is focused on identifying, incubating and accelerating novel technologies to advance progress for curing cancer and neurodegenerative diseases.
Ivan Kirchev, Senior Counsel, Hewlett Packard Enterprise
Ivan Kirchev is senior IP licensing counsel at Hewlett Packard Enterprise (HPE). He has significant experience in all areas of intellectual property, including licensing and IP transactions, patent acquisitions and divestitures, patent and tech licensing, portfolio development and strategy, IP litigation and legal opinions. As a member of HPE’s IP licensing team, Mr Kirchev is responsible for extracting value from the company’s intellectual property by executing all activities around identifying, analyzing and closing various IP-related transactions. He participates in the negotiating and drafting of various IP agreements and licenses (e.g., cross-licenses, outbound patent licenses, technology transfers, software license agreements, joint development agreements and non-disclosure agreements). He works closely with the rest of HPE’s IP team and businesses to provide strategic IP-related counselling to different internal groups relating to products, patents and competitors in order to identify, analyze and advise on IP issues and opportunities. Mr Kirchev also works on divestitures, patent sales and acquisitions, and standards licensing. He also collaborates with the IP litigation team to handle third-party patent demands and to prepare for and participate in litigation disputes involving HPE’s patents. He regularly identifies valuable IP technologies (e.g., know-how, patents, trademarks and copyright) in the company and derives value from this intellectual property, by protecting its exclusivity or licensing it.
Heather R. Kissling, Partner and Prosecution Practice Chair, Marshall & Gerstein
Heather R. Kissling, Partner and Prosecution Practice Chair at Marshall & Gerstein. Heather R. Kissling draws from over 20 years of experience securing biotechnology patents to develop worldwide filing and prosecution strategies that further her clients’ business objectives. She actively collaborates with bench scientists, business development personnel, CEOs, and in-house counsel to maximize protection of biotechnology innovations in a broad range of technologies. Heather was recognized in the 2016 Women Worth Watching list by Profiles in Diversity Journal, a list highlighting women who are using their influence to change their workplace, marketplace, and the world. More recently, she was recognized in the 2020 edition of Managing IP’s Top 250 Women in IP.
Jay Knobloch, EVP for IP, NuCurrent, Inc.
Jay Knobloch is EVP for IP at NuCurrent, Inc., an industry leader in wireless power systems and technology development. Knobloch brings to NuCurrent an extensive background in IP licensing, litigation and settlements, having spent the past eight years in a similar capacity at Trading Technologies International, and several years as a patent attorney and agent at Brinks Hofer Gilson & Lione. An engineer by training, Knobloch holds a BS in electrical engineering from Arizona State University and a JD from DePaul University.
Jhon Kong, Global Director of Compliance and License Management Services, TIBCO Software
Jhon is the current founder and Global Director of TIBCO’s license compliance program. Main areas of focus include IP Protection around end user engagements, partner end users and royalties.
Michael Koptiw, Partner, Condo Roccia Koptiw LLP
Michael Koptiw is a partner with intellectual property (IP) boutique Condo Roccia Koptiw LLP, in Philadelphia. Mike is frequently at the intersection between technology and patent law – whether it’s his strong interest in patent analytics or his years of work protecting innovation in cutting edge areas such as telecommunications (5G), home automation, and artificial intelligence (AI). Mike is deeply invested in his clients’ need for predictability in the face of the Alice/Mayo test, and has closely followed efforts reform the law of patent eligibility. Through the CRK blog and in-person events, Mike has advocated for the need for certainty in this area of the law. Mike’s practice focuses on opinion work and patent portfolio management, which is the cornerstone service of his firm.
Raja Krishnan, Commercialization Manager, University of Kentucky
Raja Krishnan is a Commercialization Manager for the Office of Technology Commercialization (OTC) at University of Kentucky (UK). His primary responsibilities include assessment, marketing and licensing of intellectual property focused on the life sciences area covering inventions from UK’s Colleges of Pharmacy and Medicine. Previous commercialization experience includes working as an intellectual property manager at the Illinois Institute of Technology OTC. Previous to that Raja spent more than 15 years working in roles of increasing responsibility in product development for various pharmaceutical companies and led the development through the launch of multiple commercial products. Raja has also consulted and advised several startup companies, including coaching teams through business plan competitions. He is a graduate of Steve Blank’s Lean Launchpad Program for Life Sciences and serves as a judge in the UK’s Entrepreneurs Bootcamp. Raja received a Bachelor of Science in chemical engineering from Cornell University, a Master of Science in pharmaceutics from Long Island University, a Master of Science in Law from Northwestern University, and most recently a Master of Business Administration from the University of Notre Dame.
Kannan Krishnaswami, Technology Commercialization Manager, Pacific Northwest National Laboratory – PNNL
Kannan Krishnaswami is a Technology Commercialization Manager located in the Richland office. In this role, Kannan stewards a portfolio of national and homeland security technologies that includes sensors, cybersecurity, and data analytical innovations. He is responsible for identifying and capturing intellectual property, its development and demonstration, and ultimately leading to its transfer to industry for productization and implementation to enhance the security of our nation and its critical assets. Kannan joined PNNL in 2004 as research scientist working on infrared remote sensing technologies for nuclear nonproliferation applications and subsequently transitioned to managing the internal research investments portfolio for the National Security Directorate before becoming Commercialization Manager. He earned his Ph.D. in Physics from the University of Massachusetts in Lowell and his MBA from the University of Washington in Seattle.
Katherine Ku, Chief Licensing Advisor, Wilson Sonsini
Katharine Ku is currently serving as Chief Licensing Advisor at Wilson Sonsini Goodrich & Rosati. Previously, she was Executive Director of Stanford University’s Office of Technology Licensing (OTL) for 27 years, until 2018. Ku was President of the Association of University Technology Managers (AUTM) from 1988-90. She received the AUTM 2001 Bayh-Dole Award for her efforts in university technology transfer. In 1999, Stanford OTL received the LES Achievement Award.
Ku is currently a member of the Visiting Committee for Advanced Technology of the National Institute of Standards and Technology (NIST). Ku has a B.S. Chemical Engineering (Cornell University), an M.S. in Chemical Engineering (Washington University in St. Louis) and is a registered patent agent.
Joe Kucera, Director IP Strategy, Pure Storage
Joe is an experienced intellectual property strategist and seasoned licensing professional with over a decade of patent licensing experience, both inbound and outbound, engaging top tier technology companies around the globe. Prior to Pure Storage, Joe had positions at Rambus, Intellectual Ventures, Spansion, and AMD.
Angela Kujak, Senior Director of Contracts, University of California, Los Angeles
Angi Kujak joined UCLA’s Technology Development Group in November 2017 to serve as its first Director of Contracts, which position was created to improve the consistency, quality and efficiency of TDG’s IP transaction negotiations. Angi is a registered patent attorney and provides IP transactional support to the Associate Vice Chancellor, and President & CEO of UCLA Technology Development Corporation, TDG’s Licensing Directors and Officers, as well as its Industry Sponsored Research team members. Such support includes aiding in accelerating negotiations to execution, enhancing licensing strategy, and providing IP-related advice on copyright, trademark and patent matters and use of name. Her responsibilities also include drafting and negotiating a broad range of IP transactions and addressing complex technology commercialization issues, including those that uniquely arise from start-up company activities. Prior to joining TDG, Angi served as Assistant and Associate General Counsel for the Wisconsin Alumni Research Foundation for over seven years, and worked as a patent prosecution and litigation attorney at a private law firm for several years before specializing in IP transactions.
Candice Landry, Commercial Manager, Chevron
Committed to bridging the transition from R&D to commercialization, Candice advocates for cross-functional innovation strategy to enable long-term IP asset value. She specializes in commercializing new technologies and preserving the value of technology investments. Candice has been recognized for leadership in innovation management and mentoring.
After earning a BS in Microbiology, she earned a PhD in Cell & Molecular Biology, then an MBA specializing in Management & Finance. Candice is licensed to practice patent law in the United States. She served on the board of the American Marketing Association and as a Mentor at the UH Wolff Center for Entrepreneurship. Candice remains active in several professional organizations and contributes to STEM initiatives in K-12 education.
Michael Lasinski, Senior Managing Director, Ankura Consulting Group, LLC
Michael J. Lasinski is a Senior Managing Director at Ankura based in Ann Arbor and Chicago. Michael’s consulting practice has focused on the financial aspects of intellectual property since 1995. He has valued intellectual property and businesses in the context of licensing, sales, mergers, acquisitions, investments, tax matters, bankruptcy, litigation, as well as many other contexts. During his professional career, he has completed hundreds of valuations of intellectual property assets. Michael has spoken on the topics of intellectual property valuation, litigation, licensing, and tax matters throughout the US and internationally.
Michael has been retained to provide expert testimony in federal, state, tax, bankruptcy, International Trade, arbitration and international proceedings. He has worked on behalf of both licensees and licensors in Fair Reasonable And Non-Discriminatory (FRAND) negotiations, litigations and arbitrations throughout the world. He has been retained by both taxpayers and the IRS to determine intellectual property value and royalty rates in transfer pricing and other tax-related transactions. While Michael’s analyses vary from case-to-case he has quantified lost profits, unjust enrichment, price erosion, reasonable royalty, diminished business value as well as other forms of economic damages.
Michael is a past President of the Licensing Executives Society – United States and Canada (LES). LES is one of the country’s largest intellectual property licensing trade organizations. He is a past Division Chair of the American Bar Association’s IP Section. He is a former Chair of the Valuation and Taxation Committee of LES and a former Vice Chair of the Intellectual Property Owners Association’s Valuation and Taxation Committee. He was also named one of the World’s 250 Leading IP Strategists by Intellectual Asset Magazine.
Ron Laurie, Executive Chairman & CIPO, InventionShare
Ron Laurie has worked in Silicon Valley since before it had that name, initially as a systems engineer and then as an IP lawyer and strategist. Ron was a founding partner of the Silicon Valley offices of the Irell & Manella, Weil, Gotshal and Skadden Arps law firms and has taught IP strategy courses at Stanford and Boalt (UC-Berkeley) law schools.
While at Skadden, Ron founded the IP Strategy and Transaction practice group and managed IP diligence teams in over $50B worth of M&A, corporate spin-out and joint venture transactions. Upon retirement from Skadden in 2004, Ron turned in his bar card and founded Inflexion Point Strategy, the first IP-focused boutique investment bank.
In 2017, Ron became Chairman and CIPO at Inventionshare, Inc., a new kind of early stage fund that finds truly breakthrough inventions and transforms them into broadly patented platform technologies that can be productized by global companies across a broad range of applications and markets.
Tomson Lee, patent and licensing business, City University of Hong Kong
Mr. Tomson Lee, P. Eng., graduated from the University of Toronto and received his Professional Engineer license in 1984. He spent 30 years in the defensive industries, and later on worked for IBM research for business development and technology licensing in Asia Pacific. For the last ten years, he has worked for City University of Hong Kong for patent and licensing business; and highly involved in the technology transfer activities in the Greater Bay areas in Southern China.
Russell E. Levine, Partner, Kirkland & Ellis LLP
Russell E. Levine is a partner at Kirkland & Ellis LLP where he has spent his entire 30+ year career. He focuses his trial, appellate and alternative dispute resolution practice on patent infringement matters and disputes involving, and relating to, technology transfer and patent license agreements. His trial practice includes jury trials, arbitrations and section 337 proceedings before the U.S. International Trade Commission. His appellate practice concentrates on appeals in the Court of Appeals for the Federal Circuit. His technology transfer and licensing practice includes structuring and negotiating both licensing-in and licensing-out transactions. He is a Certified Licensing Professional.
Russell has received many accolades for his IP practice. His strategy of seeking and obtaining a writ of mandamus earned “stand-out” recognition in the Financial Times, U.S. Innovative Lawyers 2011. He also won the International Law Office 2012 Client Choice Award in Litigation for the U.S. The clients ILO interviewed had this to say about him: “Russell has that unique ability to provide legal advice in a manner that is understandable, practical and useful for our business.”
Russell is included in Managing Intellectual Property 2019 “IP Stars,” as he has been for several years. In the 2014 edition of IP Stars, a firm client praised Russell, noting, “We have worked with Russell Levine for several years. I find he has great insight into how to give clear, concise input focused on legal solutions that leverage business needs.”
Russell is named in the 2019 editions of IAM Patent 1000: The World’s Leading Patent Practitioners and IAM Strategy 300: The World’s Leading IP Strategists. Comments in these and previous IAM publications have included: “He is fantastic and has a knack for breaking down complex subjects to their essentials without getting caught in the weeds. He really knows his audience and how to get points across effectively;” he is “well known for the depth of his licensing expertise;” and “for the most important cases, he is one of the leading figures in Chicago and nationally.”
Russell is active in bar associations, industry organizations and his community. He is a Past-President of LES (USA and Canada); a past-chair of the By-Laws Committee of the Midwest Section of the United States Tennis Association; and a past-chair of the President’s Council at Chicago’s Museum of Science and Industry.
He is an author and frequent speaker on IP issues. He is co-editor of International Licensing and Technology Transfer: Practice and the Law. His “Top 10 Court Decisions of Year” workshop at the LES Annual Meeting is consistently standing room only.
Russell holds a B.S. in Engineering and a B.S. in Economics, both degrees from the University of Michigan. He received his law degree from the University of Chicago. He is on the World Intellectual Property Organization’s List of Mediators and Arbitrators, and he is registered to practice before the United States Patent and Trademark Office.
Sam Liggero, Professor of the Practice, Tufts University Gordon Institute
Dr. Samuel H. Liggero, formerly CTO and co-founder of AirPrint Networks, has spent over thirty years in the Imaging Industry as an executive at Polaroid Corporation. Until November 2001, he was Corporate Vice President and Program Fellow of Research and Development for Polaroid’s Instant Digital Printing division. Under Dr. Liggero’s direction, Polaroid developed the groundbreaking digital printing technologies code-named Opal and Onyx. These technologies, which delivered high quality thermal prints from digital files at low cost and faster than any other technology in the marketplace, were further developed and commercialized by Zink Imaging.
Dr. Liggero joined Polaroid in 1970 and held leadership positions in research and development, manufacturing, sales and marketing, training and education, and customer service. He is the co-inventor of Polaroid’s 35 mm Instant Slide System, the founding Director of Polaroid’s Applications Group and the founding Director of the Company’s Customer Care Center. He also served as Corporate Vice President and Program Fellow for New Product Development, Commercial Imaging.
Since leaving Polaroid, Dr. Liggero started a consulting business and also co-founded AirPrint Networks. This software start-up company was funded and in operation from 2003 – 2008. The initial product was a system that enabled mobile phones to print images and text information instantly and securely, anyplace, anytime. From 2004-2007, Dr. Liggero was an Expert Witness in patent infringement litigation involving two high profile, multi-national corporations.
Dr. Liggero also teaches Digital Photography Courses in the Needham Adult Education Program. He holds a Bachelor of Science in Chemistry from Fordham University, a Ph.D. in Physical Organic Chemistry from Georgetown University and was an NIH Postdoctoral Fellow at Princeton University.
Bethany Loftin, Interagency Policy & iEdison Specialist, National Institute of Standards and Technology
Bethany Loftin is an Interagency Policy and iEdison Specialist in the Technology Partnerships Office (TPO) at the National Institute of Standards and Technology (NIST). She works on the coordination and redesign of the iEdison website and acts as a liaison for federal agencies and external users of the iEdison system. Bethany also assists with policy formulation and implementation with an emphasis on Bayh-Dole regulations and coordinates the interagency working group for Bayh-Dole. Prior to joining TPO, Bethany spent more than eight years as Director and Chief Operating Officer at TreMonti Consulting. While at TreMonti, she supported numerous technology transfer offices throughout all steps of the commercialization process, including best practices as well as Bayh-Dole and iEdison Compliance. Bethany holds a JD from the University of Louisville and a BS in Recording Industry from Middle Tennessee State University.
Qing Lyu, Attorney, HL Fidelity
Qing advises Chinese companies, as well as multinationals, on various antitrust and public procurement matters, including cartel and unilateral conduct investigations and merger filings in China. She also assists clients with antitrust investigation by the U.S. Fair Trade Commission, and supports Chinese companies in response to proposed export control sanction by U.S. Department of Commerce.
Charles R. Macedo, Partner, Amster, Rothstein & Ebenstein
Charles R. Macedo is a partner at Amster, Rothstein & Ebenstein. He advises and litigates in all areas of intellectual property law, including patent, trademark and copyright law, with a special emphasis in computer implemented inventions. He also assists clients in obtaining, maintaining and enforcing patent, trademark and copyright portfolios.
Mr. Macedo is also the author of the book, The Corporate Insider’s Guide to U.S. Patent Practice, originally published by Oxford University Press.
MK Marsden, Chief Advisor, Avasta Inc
MK, a computer scientist by education, leads Avasta’s Board Advisory Practice, dedicating her efforts toward working on board and executive leadership governance and technologies so that companies change how they measure and manage the definition of success.
Over her 35-year career across three continents she has built a global, data driven presence for companies such as Novell, Acxiom, and Epsilon. She is also a founder of eight companies in her career and has been instrumental in growing multiple companies from start-ups to over $1bn in value. MK has also had thorough participation in over 40 M&A transactions including selling two of her own companies.
Additionally, as a certified board member, ICD.D, MK bridges the communications requirements between investors & shareholders, the board, and the executive leadership of corporations. MK has sat on the board of Fujitsu, multiple private equity firms, and numerous technology-oriented corporations as an independent director.
Christopher Martinez, Managing Partner, StoneTurn
Christopher Martinez, a co-founder of StoneTurn and the firm’s Managing Partner, has more than 25 years of experience in intellectual property (“IP”) damages quantification, intellectual asset licensing and complex financial modeling.
Christopher advises companies on the valuation, commercialization, licensing and management of intellectual assets. As a former licensing executive of a Fortune 50 enterprise, he brings a unique and experience-based approach to the quantification of patent, trademark and copyright infringement damages, as well as trade secret misappropriation damages. Additionally, he has designed, implemented and executed royalty inspection programs on behalf of clients to facilitate the capture of the appropriate return on licensed intellectual assets. He possesses an understanding of accounting and financial valuation issues that impact intellectual assets, as well as the economic principles related to business transactions in general, and IP / technology transfer transactions in particular.
Christopher also has extensive experience in quantifying economic damages in the context of breach of contract, business interruption, change of scope, and delay and disruption allegations. He has conducted contract compliance evaluations and other fact-finding investigations, and has served as an expert in many disputes.
Christopher has worked with clients across a range of industries, including the pharmaceutical, biotechnology, medical device, semiconductor, telecommunications, Internet / e-Commerce and software sectors.
Christopher has been designated as an expert in Federal court (Northern, Central and Southern Districts of California; Northern, Southern, Eastern and Western Districts of Texas; Eastern and Western Districts of Virginia; Southern District of New York; Delaware; Massachusetts; Northern District of Ohio), State court (California, Texas, Florida, Virginia), United States Trade Commission (“USITC”) actions, as well as in arbitration proceedings.
Christopher has been recognized as a top economic patent damages expert in IAM’s Patent 1000 since its inception in 2014. Clients recognize Christopher as “a clear-sighted analyst of the financial issues arising from IP and transactional disputes. A veteran witness and consultant, he also benefits from commercial insights gained as a licensing executive at a Fortune 50 corporation.”
Christopher has served as a speaker on intellectual property-related issues at events hosted by the Practicing Law Institute (“PLI”), Licensing Executives Society, American Intellectual Property Law Association (“AIPLA”), University of Texas, Stanford University, UC Berkeley, American Bar Association, Semico, Drug Information Association, among others. He is a Certified Public Accountant (licensed in the state of California), Certified Patent Valuation Analyst and Certified Licensing Professional (“CLP”).
John McCracken, Consultant, McCracken Pharma LLC
Pharmaceutical business development professional with extensive pharmaceutical industry network with experience supporting Big Pharma, Specialty Pharma, Generics, Drug Delivery, Hospital Products and Biotechnology companies. Have successfully negotiated and executed more that 50 BD transactions (product and technology in-licenses, out-licenses, product divestitures, supply agreements, authorized generic licenses and loss of exclusivity management transactions). Skilled in management of the full range of BD activities including search, evaluation, deal term negotiations, due diligence, contract negotiations/renegotiations and Alliance Management.
Megan McLoughlin, Director of Product Management, LexisNexis Intellectual Property
Megan McLoughlin is the Product Director for LexisNexis PatentAdisor, a suite of patent prosecution management tools. Previously, she worked as a patent attorney at the law firm of Nutter, McClennen, & Fish. Her technical focus reached into a variety of industries, including medical devices, the food industry, software, printers, and biotech. She is the cohost of the podcast Better Patents Now, which explores topics related to patent law and prosecution analytics.
Bryan Mechell, Partner, Robins Kaplan LLP
Bryan Mechell focuses his practice on new and cutting-edge technologies in order to help large companies, small businesses, and inventors assess and protect the value of their intellectual property. Bryan regularly represents emerging and established businesses involved in technology and license disputes and helps them develop methods for auditing, managing, and enforcing license compliance. As a trial lawyer and registered patent attorney with experience in complex patent litigation, Bryan represents clients as both plaintiffs and defendants in various phases of litigation—including trial proceedings conducted by the Patent Trial and Appeal Board—and has experience identifying and implementing strategies to clearly and persuasively present complex legal and technical issues in order to drive business-oriented solutions.
Sergey Medvedev, Partner, Gorodissky & Partners (Mosocow)
Sergey Medvedev is a Partner working in the Moscow office of the law firm “Gorodissky & Partners” (Russia). He specializes in various legal issues related to protection, acquisition, exploitation, licensing, litigation and enforcement of IP and IT rights in Russia and CIS. Sergey deals with various types of IP/IT, including copyrights and related rights, software and databases, patents and designs, trademarks, brands and domain names. He also deals with know-how and confidential information as well as privacy and data protection. Sergey provides legal support to national and international clients in connection with different transactions related to disposal and conveyance of IP/IT assets. He is regularly in charge of developing, reviewing, negotiating and perfecting (registering) licensing agreements, franchising contracts, security interests and other contractual arrangements. Sergey is also involved in heavy-weight M&A, joint venture and investment projects, IP/IT legal due diligence and IP/IT transfer process. Sergey litigates IP/IT rights and combats with unlawful/unauthorized use of IP/IT and illegal content on the Internet, unfair competition and false advertising, parallel imports and grey market goods, counterfeits and piracy. He represents the interests of domestic and foreign clients in courts and with local law enforcement agencies on different IP/IT infringement matters. Sergey participates in extra-judicial as well as judicial dispute resolution actions, civil procedures, administrative and criminal proceedings. He is the author of a number of articles and works published by the leading Russian and international publishing houses. Member of Licensing Executives Society International (LESI) and other professional organizations.
Stephanie Miller, Ph.D., Executive Director, Technology Transfer and Research Park Initiatives, Embry-Riddle Aeronautical University
Dr. Stephanie Miller joined Embry-Riddle Aeronautical University in May 2013 to establish the university’s first technology transfer office, enabling university research results to become real-world products. In this capacity she evaluates ERAU inventions for commercialization potential and markets those assets to industry for licensing, development, and production. In addition, she advises and assists ERAU faculty, staff, and students to spin out their university-generated technologies into newly formed ventures. In the spring of 2016, Dr. Miller joined the faculty in the ERAU College of Business to teach Entrepreneurship. In her newest role as the Executive Director of Technology Transfer and Research Park Initiatives, Dr. Miller manages operations at the Embry-Riddle Research Park including the MicaPlex Technology Business Incubator. Most recently, she was recently named the Private Sector Young Professional of the Year and one of the community’s 40 Under Forty by the Dayton Beach News Journal. She previously held positions at the University of Virginia Licensing & Ventures Group, evaluating and marketing technologies primarily in the areas of medical diagnostics and therapeutics. Miller earned her B.S. in Biotechnology at the University of Delaware, her M.S. in Biological and Physical Sciences and Ph.D. in Biochemistry and Molecular Genetics from the University of Virginia, and her M.B.A. from Embry-Riddle Aeronautical University.
Carol Mimura, Asst. Vice Chancellor, IP & Industry Research Alliances (IPIRA), U.C. Berkeley
Carol Mimura, Ph.D., RTTP is the Assistant Vice Chancellor for Intellectual Property & Industry Research Alliances (IPIRA) at the University of California, Berkeley.
She has served as an Executive Director of U.C. Berkeley’s Office of Technology Licensing, on the boards of the Children’s Hospital Research Institute in Oakland, CA and BayBio, the regional voice of biotechnology in Northern California. She received a Deal of Distinction from LES for leading a team that negotiated a $500M research agreement and a Patents for Humanity award from the U.S. Patent and Trademark Office. She patented, licensed and monetized a drug royalty for on an early immunotherapy for which the lead inventor won a Nobel prize in medicine.
Prior to her positions at U.C. Berkeley, Carol was an analyst at Technology Forecasters, and a consultant to Cor Therapeutics and Genomyx. She holds a Bachelor of Science degree from Yale University in Molecular Biophysics & Biochemistry and Ph.D. in Biology (biochemistry and microbiology concentration) from Boston University. She was an NIH-sponsored postdoctoral fellow and research scientist at U.C. Berkeley in Biochemistry and in Chemical Biodynamics.
Her public policy publications include:
Mimura, C., “Nuanced Management of IP Rights: Shaping Industry-University Relationships to Promote Social Impact”, Chapter 9 in Working Within the Boundaries of Intellectual Property, Oxford University Press, pp. 269-295, March 4, 2010. Ed. By Rochelle Dreyfuss, Harry First, Diane Zimmerman.
Mimura, C. Julie Cheng and Braden Penhoet, “Socially Responsible Licensing, Euclidean Innovation and the Valley of Death”, Perspective in Stanford Journal of Law, Science and Policy.
Michael Miron, Founder of Xerox Internet Business Group, ContentGuard, VP Corp Strategy & Development AirTouch, Salomon Brothers and McKinsey – implementing transformative technology
Michael Miron founded Xerox Internet Business Group (consolidated research labs and IP Holding Company) and ContentGuard (DRM)
VP Corp Strategy & Development AirTouch (became part of Verizon)
Salomon Brothers and McKinsey – implementing transformative technology
Dr. Daria Mochly-Rosen, President and Founder, SPARK GLOBAL
Dr. Mochly-Rosen, a protein chemist in the chemical and systems biology department at Stanford University, leads multi-disciplinary research on the molecular mechanisms of diseases. She also serves as the Chair of her department (2001-2004) and the Senior Associate Dean for Research (2006-2013) at Stanford University, School of Medicine. Dr. Mochly-Rosen has authored more than 280 published articles and dozens of patents.
Dr. Mochly-Rosen founded three biotech companies, including KAI Pharmaceuticals (acquired by Amgen and KAI’s product, Parasbiv, is approved). Her experience translating basic research to drug development efforts led her to found SPARK, Stanford’s translational research program. Now in its 13th year, SPARK has a greater than 60 percent success rate each year, as measured by licensed projects to excising companies (14) or startups (40) and/or conducting clinical studies (38), addressing local and global health care needs. The SPARK model has been adopted by more than 70 institutes on all continents, and Dr. Mochly-Rosen serves as president and founder of the SPARK GLOBAL organization.
C.G. Moore, Partner, McBee Moore & Vanik IP, LLC (MMV IP Law)
C.G. Moore, Ph.D. is a registered patent attorney and a member of our firm’s Intellectual Property Practice. Dr. Moore concentrates his practice in the fields of biotechnology and chemistry, with a particular emphasis on molecular and cellular biology, small molecule chemistry, medical devices, agricultural chemistry, and food additives.
CG has a particular expertise in AI and its interplay with IP and particularly in the biotech patent assessment and white space analysis arena.
In addition to the preparation and prosecution of patent applications, C.G. also has broad experience with ex parte reexamination and inter partes review proceedings, appeals to the Patent Trial and Appeal Board (PTAB), managing patent portfolios, drafting patent licenses and opinions, performing due diligence in connection with public financings and acquisitions, and support of litigation involving patents and trademarks.
C.G. gained significant research experience in the life sciences through his work as a research assistant at the Oregon Health Sciences University and later at the Massachusetts General Hospital. He also acquired first-hand experience with the biotechnology industry while working with the New England Organ Bank and the Transplant Resource Center of Maryland.
As a Ph.D. candidate at the Johns Hopkins University School of Medicine, his doctoral research focused on the regulation of glutamate receptors and their interaction with Homer proteins, demonstrating a role for coordinated phosphorylation and isomerization.
Jeffrey Morton, Partner, Snell & Wilmer L.L.P.
Jeff has significant patent prosecution and strategic patent counseling experience in a wide range of technology areas including genomics, immunology, molecular biology, and organic chemistry. He also has an active trademark and transactional practice, and has represented clients in numerous intellectual property-related transactions. He is regularly called upon to give timely and cost-effective advice when clients are commercializing their intellectual property assets. Due to his bar admissions in the United States and Canada, Jeff’s practice includes providing cross-border advice to Canadian clients operating in the U.S., and vice versa.
Craig Moss, EVP, Ethisphere
Craig Moss is Executive Vice President of Ethisphere. Craig is a leading expert on using management systems to improve compliance and risk management performance within companies and across supply chains.
Craig is Chairman of the Licensing Executives Society committee for developing an ANSI global standard for IP Protection in the Supply Chain. He is also the Director-Content & Tools at the Cyber Readiness Institute, an organization focused on helping small and mid-sized businesses in the value chain improve their cyber readiness. Craig is a Director of the Digital Supply Chain Institute, where he developed a transformation catalyst program, featuring a unique new data trading framework.
At Ethisphere, Craig is responsible for developing and delivering the Measure and Improve program designed to help companies and their supply chain companies mature their programs for cybersecurity, protection of intellectual property and anti-corruption. He has designed and led numerous programs helping Fortune 500 companies around the world to implement management systems to reduce supply chain risk and improve performance.
DJ Nag, Chief Investment Officer, Ventech Solutions
Dr. DJ Nag is the Chief Partnership Officer at Ventech Solutions, a healthcare technology company that manages quality data for the Center for Medicare and Medicaid Services (CMS). He has successfully led Ohio State University, Rutgers University and University of Nebraska’s technology transfer operations that included licensing, startup and investments. As an entrepreneur he led a number of start-ups in the intellectual property strategy, artificial intelligence, and medical device space. As a consultant in patent monetization and intellectual property strategy he has worked with many Fortune 500 companies, universities, and national governments. He was a Director of Ocean Tomo and a Vice President at ICAP Ocean Tomo leading patent transaction markets. He was recognized as one of the top IP strategists by IAM300 in 2019. DJ was on the Board of AUTM from 2012-14 focused on educating the members around world the importance of technology transfer and intellectual property. He is widely recognized as a global intellectual property strategist working with government and universities in Poland, Japan, India, Turkey, Brazil, South Korea, Ukraine and many other countries. Currently he teaches intellectual property strategy and negotiations as a Professor of Practice at Rutgers University and a Visiting Professor at Shizuoka University. He volunteers as the first Executive-in-Residence at the Dublin City Schools leading a startup academy for high school students and serves on the foundation board at the Dublin Methodist Hospital.
Nicole Nan, Partner, Dinsmore & Shohl LLP
Nicole focuses her practice on drafting and negotiating agreements governing the creation and licensing of intellectual property and litigation relating to patent infringement.
As part of her licensing practice, she drafts and negotiates agreements relating to the transfer of intellectual property, with a focus on supporting clients’ research and development efforts with universities and other companies. She is a certified licensing professional and has negotiated hundreds of technology agreements, including sponsored research agreements with universities and joint development agreements with companies where intellectual property concerns play a key role in the transaction. Nicole also has experience drafting and negotiating agreements for the licensing of various types of intellectual property, including patents, technology, and software.
As part of her litigation practice, Nicole understands that patent infringement matters are often complex and time-intensive. She utilizes a thorough approach, performing methodical research and learning her client’s objectives and tolerances to help tailor a strategy for an efficient and practical resolution. She is adept at working with technologies in a variety of industries, from automotive to chemical technologies, as she draws on her experience working for two biotechnology start-up companies and two large research university technology commercialization offices.
Sean O'Connor, Professor of Law & Executive Director, George Mason University, Center for Protection of IP (CPIP)
Sean O’Connor is Professor of Law, Founding Director of the Innovation Law Clinic, and Executive Director of the Center for the Protection of Intellectual Property (CPIP) at George Mason University’s Antonin Scalia Law School. His research and law practice focus on intellectual property and business law, especially the role of general counsel for start-ups and commercializing innovation in technology and arts. Professor O’Connor received his law degree from Stanford Law School, a master’s degree in philosophy concentrating on the history and philosophy of science from Arizona State University, and a bachelor’s degree in history from the University of Massachusetts, Boston. Before graduate school he was a singer-songwriter and rock band front man with two self-released albums that received local airplay in the Northeast. He is currently writing The Means of Innovation: Creation, Control, Method+ology and serving as Editor of The Oxford Handbook of Music Law & Policy, both forthcoming from Oxford University Press.
Alan Paau, lifetime honorary professor, Southwest Jiao Tong University
Dr. Alan Paau is a former Vice Provost at Cornell University from January 1, 2007 to February 28, 2015. Until August 2014, he was for seven and a half years also President of the Cornell Research Foundation, Inc. and Executive Director of the Cornell Center for Technology Enterprise & Commercialization. Previously, he was Assistant Vice Chancellor and Director of the technology transfer program at The University of California-San Diego (“UCSD”). Prior to UCSD, he was Executive Director of the Iowa State University Foundation, Inc. and the Office of Intellectual Property and Technology Transfer of Iowa State University. He supervised the execution of over 1,800 intellectual property licensing transactions to introduce useful products and services to the society and provided the technology basis for the formation of over 150 new businesses to create high-paying jobs that contributed to the economic vitality of the regions. Prior to heading the academic technology transfer efforts, he was Associate Director of the Ohio State Biotechnology Center (Columbus, OH; 1992-1994) and was a scientist, senior scientist, and manager at the Cetus and the W.R Grace & Co. organizations for twelve years (1981 – 1992) engaging in product R&D activities that resulted in two commercial products. While at Ohio State and at Iowa State, he held adjunct faculty appointments in the departments of Microbiology; Plant Pathology; Preventive Medicine, Microbiology & Immunology; and Zoology & Genetics. He currently serves on the advisory board of several biotechnology companies, academic programs, and non-profit organizations.
Dr. Paau holds a BS, a MS, and a PhD degree in Biological Sciences; a MBA degree; and attended law school. He has been a Certified Licensing Professional since 2014 and currently is a lifetime honorary professor at the Southwest Jiao Tong University (Chengdu, China) since 2012.
John Paul, Partner, Finnegan
John Paul has more than 30 years of experience in intellectual property licensing, litigation, and prosecution, with a particular focus on strategic planning, IP portfolio evaluation and development, complex transactions, due diligence investigations, and licensing and enforcement of IP portfolios to generate revenue. He leads the firm’s IP management and transaction section, and is designated as a Certified Licensing Professional (CLP).
Mike Pellegrino, Founder and President, Pellegrino & Associates, LLC (P&A)
Mike Pellegrino is the Founder and President of Pellegrino & Associates, LLC (P&A), a boutique intellectual property (IP) valuation firm. He has significant experience valuing patents and other forms of intellectual property, establishing royalty rates, and evaluating businesses. His company engagements number more than 400 for more than 200 clients, ranging from Fortune 100 companies like IBM, GE, State Farm, Liberty Mutual, American Express, and Lockheed Martin to startups. Judges, attorneys, and government entities such as the IRS and the SEC have widely accepted his work product. Courts at the state and federal level, tax jurisdictions, and arbitration panels have accepted Mike’s work for issues including bankruptcy valuations, estate tax valuations, copyright infringement claims, trade secret misappropriation claims, patent infringement claims, breach of contract claims and others. One North Carolina court stated that Mike’s work is “clearly in the mainstream of IP valuation methodologies” and that his qualifications were “outstanding.”
Mike’s experience positions him as a market leader in intangible asset valuation. He is the author of first and second editions of BVR’s Guide to Intellectual Property Valuation, selling more than 700 books to a variety of customers including attorneys, tech transfer officers, business valuation firms, competing IP valuation firms, and more. In addition, his finance- and software-related articles appear in internationally and nationally recognized outlets, such as IAM Magazine, CFO Magazine, MSNBC.com, FoxNews.com, and others.
In addition to speaking engagements, Mike teaches webinars regarding valuation and related topics. To date, students number more than 1,200 and include those across most major economic analysis firms, the IRS, financial institutions, and others. For instance, students come from Charles River Associates, Stout Risius Ross, Inc., Wells Fargo, Deloitte, Ernst & Young, JP Morgan Chase, KPMG, and PriceWaterhouseCoopers. Mike has also taught scores of technology transfer and IP managers from the likes of Baxter Healthcare, John Deere, DSM, Harley Davidson, Novelis, Johnson & Johnson, Pepsi, Nestle, Alcoa, Dow, Georgia-Pacific, Kimberly-Clark Corporation, Kraft Foods, Celanese, SC Johnson, Altria, AB Inbev, James Hardie Building Products, Avery Dennison, Vale, Exxon Mobil, United Health Group, General Electric, FedEx, The Hershey Company, and Baxa Corporation among others.
Mike has taught IP valuation concepts to officials from the governments of Brazil, Azerbaijan, Estonia, Thailand, Guatemala, and New Zealand on behalf of the U.S. State Department. He has counseled and testified before legislators about valuation issues. He was also instrumental in helping to change Indiana law regarding the valuation of embedded application software for personal property tax reporting purposes and for the taxation of patent-derived income. He authored the administrative rules that Indiana’s Department of Local Government and Finance now uses to administer the evaluation of software appraisals for property tax matters.
In addition to his valuation expertise, Mike developed a state-of-the-art patent analytics tool that provides key insights and intelligence into the patent landscape. This system removes information asymmetry rampant in the patent marketplace by consolidating millions of disparate records into a user-friendly database.
Shayne Phillips, Managing Member, Six Points Consulting, LLC
Ms. Shayne Phillips has been working in the intellectual property (IP) arena for over fifteen years, particularly in the areas of IP-related competitive intelligence and technical patent and nonpatent literature searching. Ms. Phillips began her career at Procter & Gamble (P&G) in Cincinnati, Ohio, working as a Technical Assistant in Corporate New Ventures (a group tasked with evaluating outside technology for the entirety of P&G). She then moved to the IP-practice group of Dinsmore & Shohl (also in Cincinnati), working as a Technical Consultant, providing both patent application prosecution support and IP litigation assistance. In 2000 Ms. Phillips moved to Columbus, Ohio, and began work at Chemical Abstracts Service (CAS) as an Editorial Analyst in the Mammalian Hormones Document Indexing Group of the Biochemistry Department of CAS’ Editorial Division. In 2002 she transitioned to the role of Applications Specialist at CAS, specializing in advanced STN training, focusing on protein and gene sequence searching in particular. Following her tenure at CAS, Ms. Phillips moved to Halliburton in Houston, Texas, working in their Intellectual Asset Management group as both the head of IP Competitive Intelligence and as a Senior Patent Liaison for the Cementing and Multichem Product Service Lines. Ms. Phillips holds a Bachelor of Science degree in Biology from Youngstown State University, a Master of Science degree in Biochemistry from the University of Cincinnati, and a Master of Business Administration degree from Capital University in Columbus, Ohio. She is also a registered US Patent Agent.
Leena Prabhu, Associate Director, Washington University in St. Louis
“Leena Prabhu, Ph.D., M.B.A., leads the licensing team at OTM (Office of Technology Management), which is responsible for the commercialization of technologies at The Washington University in Saint Louis. Leena and her team evaluate invention disclosures, manage patent portfolios, negotiate licenses, and develop commercialization strategies to maximize the translational impact of university technologies.
Before joining the OTM, Leena worked both as a research scientist and later as a senior licensing associate at Memorial Sloan Kettering Cancer Center. Leena has also worked at Schering Plough Pharmaceuticals (Merck) as a product management associate.
She holds a Ph.D. in Molecular Biology from I.I.Sc. (Indian Institute of Science) and an M.B.A. from Thunderbird School of Global Management.”
Sangeetha Raghavan, Senior Licensing Associate, Office of Innovation Ventures at Children’s National Medical Center
Sangeetha Raghavan is presently the Senior Licensing Associate at the Office of Innovation Ventures at Children’s National Medical Center. Prior to working at Children’s, she worked at University of Maryland’s Office of Technology Commercialization. She is a registered patent agent with the USPTO and holds multiple degrees in various disciplines including business and life sciences.
Jaysen Rajkomar, Senior Legal Counsel, Toyota Research Institute, Inc.
B. Jaysen Rajkomar is Senior Legal Counsel at Toyota Research Institute Inc., where he supports general legal matters related to machine learning, automated driving, and robotics. Previously, he worked at Stanford University’s Office of Technology Licensing / Industrial Contracts. He earned his J.D. from U.C. Davis School of Law and B.S. from U.C.L.A. He is licensed to practice law in California, and before the United States Patent and Trademark Office.
Kent Richardson, CEO, Richardson Oliver Insights
Mr. Richardson is a CEO at Richardson Oliver Insights, the authoritative source of secondary patent market information. For nine years, he has produced the most widely read annual report on the secondary patent market. He is also a Partner at ROL Group, where he counsels clients on a variety of patent and business matters including patent buying, selling, licensing, valuation, prosecution, and operations.
Mr. Richardson has licensing and marketing patent portfolio experiences resulting in more than $600M of patent license bookings. Mr. Richardson has also served as an expert witness on patent monetization and licensing practices in cases in England and the United States.
Prior to founding the Richardson Oliver Insights and ROL Group, Mr. Richardson was the General Manager of ThinkFire Services USA, Ltd’s Silicon Valley office. Mr. Richardson has worked in various senior management roles with such growth businesses as Sezmi, Constellation Capital, Rambus, Numerical Technologies, and he was also an attorney in private practice at Wilson Sonsini Goodrich & Rosati.
Mr. Richardson is a member of the California Bar and a United States Patent and Trademark Office registered patent attorney. He holds five US patents.
He holds a JD and a BSc in Computer Engineering from the University of Alberta, Canada.
Daniel Rudoy, Associate, Electrical and Computer Technologies, Wolf Greenfield and Sacks
Dan Rudoy focuses his practice on patent prosecution in the areas of artificial intelligence, bioinformatics, speech and image processing, industrial automation, Internet of Things (IoT), robotics, cybersecurity, autonomous devices, software, medical devices, computer security, networking, radar systems, and electronics. He is particularly skilled in technologies related to machine learning, including deep learning, signal processing, big data, data science and bioinformatics.
Brian Russo, Senior Director, Alliance Management, Pfizer, Inc.
Brian Russo is a Senior Director of Alliance Management for Pfizer, Inc. He has over 25 years experience managing business relationships including co-development, co-promotion, strategic sourcing and research collaborations. He currently manages multiple alliances within Pfizer’s Innovative Medicines Business Unit. Prior to joining Pfizer in 2005, Brian worked at Chiron Corporation in Emeryville, CA from 1994 to 2004. At Chiron, he held various positions including leadership of Chiron’s strategic sourcing, in-source manufacturing and external collaboration programs. Brian holds Master of Business Administration degree in Finance, with a Bachelor of Science degree in Accounting. Brian is an active member of the Association of Strategic Alliance Professionals.
Matteo Sabattini, Director IP Policy, Ericsson Inc.
Dr. Matteo Sabattini is Director of IP Policy at Ericsson and he is based in the Washington, DC, office. In his role, he is responsible for IP rights policy, advocacy, licensing and promotion at SDOs, industry fora, trade associations, governmental agencies, etc. He also serves as the Senior VP for Standards at LES USA and Canada, as the Technical Policy Coordinator at IEEE Region 2, and is a voting member of IEEE-USA IP Committee.
Matteo has years of expertise in technology and IP-related matters, and his background combines business, policy, and technical skills. He holds an MBA from the George Washington University, a Ph.D. in EE from the University of California, San Diego, and an M.S. also in EE from the University of Bologna.
Before joining Ericsson, Matteo served as the CTO of the Sisvel Group until February 2017. Matteo also worked at InterDigital and Global Prior Art, a boutique IP consulting firm based in Boston. He also held several teaching and research positions in wireless and mobile communications at UC San Diego and at the German Aerospace Center.
Matteo is an IEEE Senior Member, a Beta Gamma Sigma Lifetime Member, a member of LES and the MIT Enterprise Forum.
Kevin Schubert, Attorney, McKool Smith
Kevin Schubert is an attorney at McKool Smith. For over 10 years, he has been involved with some of the most successful patent litigations in the country. He is a frequent speaker and writer on patent law. Recently, he co-authored “IPR Estoppel Increasingly Applies,” which was named one of the most read guest articles of 2019 by Law360. Before McKool Smith, Kevin worked as a patent examiner at the U.S. Patent Office in the Cryptography department, where he examined more than 100 patent applications.
Laleh Shayesteh, Sr. Licensing Officer and Assistant Director of Administration, University of California, Berkeley
Laleh is the Assistant Director of Administration and Senior Licensing Officer at UC Berkeley’s Office of Technology Licensing where she develops IP strategy and oversees licensing for life sciences, chemistry, medical instruments, physical sciences, engineering, and software technologies. Additionally, she handles trademark and copyright matters, open source compliance, data licensing, and IP matters for government and foundation grants and contracts.
Laleh is a trained scientist and worked for several years in research before practicing law. Prior to joining UC Berkeley, she performed population genetics research at Stanford, pediatric brain tumor research and ovarian cancer research at UCSF, brain tumor research at University of Chicago, and comparative genomics research at Exelixis. She then embarked on a law career and became a patent agent at Exelixis, followed by a director of IP and assistant general counsel for IP matters at SRI.
Laleh holds a Ph.D. in Biophysics from UC San Francisco and a J.D. from Concord Law School. She is a member of California State Bar and is also registered to practice before the US Patent and Trademark Office.
Vladimir Shpilrain, Professor of Mathematics and Computer Science, City University of New York
Vladimir has developed the fastest available, totally secure Fully Homomorphic Encryption algorithm on which he has two patents.
Vladimir’s research interests include: cryptography, complexity of algorithms, data mining, combinatorial and computational group theory, affine algebraic geometry.
He splits most of his time between combinatorial group theory and cryptography (more specifically, public key cryptography).
Todd Sigler, Principal, Green Hasson Janks
Todd Sigler, Esq., CPA, CFE, CFF, has over 15 years of experience in royalty audit services with an emphasis in internal investigations and litigation support. As a leader in the Firm’s Royalty and Licensing Practice, he provides services in various industries including gaming, high technology, health sciences, consumer products and others.
Prior to joining Green Hasson Janks, Todd worked for RSM as a director in their litigation support and forensic accounting practice. His experience includes managing annual project billings and growing accounting practices from inception. He started his career in consulting at Deloitte in their financial advisory services practice.
Todd holds a Bachelor of Science degree in Accounting and Finance from California State University, Northridge, a Master of Business Administration degree from University of California, Irvine and a Juris Doctor from Loyola Law School.
Kathleen Snyder, OF COUNSEL, Wilson Sonsini
Kathleen Snyder is Of Counsel in the Boston office of Wilson Sonsini Goodrich and Rosati, where she is a member of the technology transactions practice and a leader of the firm’s digital health initiative. Her practice focuses on the intersection of healthcare and technology, providing clients with strategic actionable legal advice with regard to drafting and negotiation of commercial contracts, data strategies, intellectual property, and regulatory interpretation.
Nicole Spence, IP Attorney, Cross Brands IBM
For more than three years, Nicole A. Spence has practiced as an intellectual property attorney at IBM, where she currently supports the IBM Watson AI and The Weather Channel brands. Prior to IBM, Nicole practiced as a litigator in intellectual property and insurance defense for two different law firms. She also owned her own law firm, where she practiced intellectual property and corporate law for start-ups and small to medium-sized business clients in tech, fashion and culinary arts.
Derek Stettner, Partner, Michael Best & Friedrich
Partner, Co-Chair Digital Technology Industry Group, and Leader of the Electrical Engineering and Computer Science Intellectual Property Subgroup. Practicing for over 25 years. Manages patent preparation and global prosecution for Fortune 500 and multi-national corporations. Provides counsel on protecting software, computer, and electrical technologies by securing patent, copyright, and other intellectual property protection.
Deborah Stewart, Managing Director, InvotexIP
Debora R. Stewart, CPA – Managing Director with InvotexIP. InvotexIP is a consulting firm that specializes in royalty audits and compliance. Ms. Stewart is a Certified Public Accountant with more than 25 years’ experience working with corporations, universities, government entities and their counsel in the intellectual property area. Debbie was at the forefront of the royalty audit industry as one of the first professionals who understood the unique relationship between the licensor and licensee. She is dedicated to helping clients proactively manage their license royalty reporting and revenue. Arguably, Debbie has personally managed more patent royalty audits than anyone else in the industry. Her firm is known for the ability to uncover large underpayments while preserving the licensor-licensee relationship.
Paul A. Stewart, Managing Director, PASCO Ventures LLC
Paul A. Stewart is Managing Director of PASCO Ventures LLC, a Denver-based independent advisory firm he founded after retiring from Eli Lilly and Company in 2012. He has deep expertise in licensing from over 25 years of executive and leadership experience and through completing global and regional transactions in the Americas, Europe, Africa and Asia. These transactions have produced over a dozen human pharmaceuticals, medical devices and animal health products that are in the market today or have been publicly disclosed while in development, plus other as-yet-undisclosed developments.
Stewart has led and served on numerous professional, academic, civic and not-for-profit boards, is a Certified Licensing Professional, is listed in “Who’s Who in America,” “Who’s Who in the World” and “Who’s Who in Medicine and Healthcare,” and is the author of “A Harvard MBA’s Advice to His Sons” (ISBN 1594539952). He also served as a distinguished lecturer for the Graduate Program of International Pharmaceutical Engineering Management (IPEM) at Peking University in Beijing, China.
Stewart received a Bachelor of Science degree in agricultural business management from Purdue University and a Master of Business Administration degree from Harvard Business School.
Mark Stignani, Analytics Practice Group Chair, Barnes & Thornburg
Mark Stignani chairs the Analytics Practice Group at Barnes & Thornburg. Mark uses a blend of AI/Machine learning analytical tools and decades of corporate practice to offer a unique set of insights to his clients above and beyond simple legal advice.
Mark has held several global corporate counsel roles while practicing all forms of intellectual property, M&A, contract negotiations, as well as other high technology legal subjects. He serves as advisor to several other global companies on product innovation/portfolio management as well as providing strategic insights and behavioral inferences with his clients and their competitor portfolios.
Manny Stockman, Principal, Technology, Osage University Partners
Manny joined Osage University Partners in 2015. At Osage, he has focused on core technology areas across software, computing, and IoT. He is a board director at PsiKick, an observer at NuMat, and has led Osage’s investments in SiFive and IonQ. Prior to joining Osage, Manny was at Lockheed Martin ATL and Skunkworks. As an engineer executing on the transition of early stage technologies into the defense industry, he often joined university researchers with his industry team to develop unique technology solutions across the materials, applied physics and photonics domains.
Manny holds a Ph.D. from Princeton University in Aerospace Engineering and Applied Physics and a B.S.E in Mechanical Engineering from Duke University. He lives in Philadelphia with his wife and two daughters.
Jason Stolworthy, Director of Technology Deployment, Idaho National Laboratory
Jason Stolworthy is Idaho National Laboratory’s Director of Technology Deployment. Over his career, Jason has specialized all matters related to innovating, protecting, transferring and commercializing technologies developed from research in diverse environments at Universities, Private International Organizations and National Laboratories. Since the beginning of his career, Stolworthy has specialized in turning around or starting-up technology transfer offices. Most recently Jason served as the Director of Intellectual Property Management for the Qatar Foundation Stolworthy to establish Qatar’s first intellectual property management, define Qatar’s national technology transfer strategies and technology transfer office, which now manages more than 400 inventions, protects over 300 patents and serves over 600 inventors advance their ideas. Stolworthy joined INL in 2016 with the goal to significantly increase INL’s performance in deploying technologies, including implementing innovation methodologies and entrepreneurial culture strategies. Stolworthy is a registered patent attorney and holds bachelor’s degrees from Idaho State University in chemistry and biochemistry, a master’s from University of Idaho in chemical engineering and a Juris Doctor from University of Idaho College of Law.
Ryan Sulkin, Partner, Michael Best & Friedrich
Ryan has a robust background in privacy and cybersecurity and focuses his practice in the areas of information technology, outsourcing, data protection, licensing, e-commerce, and intellectual property. He serves clients across industry sectors, including financial services, hospitality, manufacturing, and pharmaceuticals.
Ryan provides expert counsel to numerous well-known, global consumer and business-to-business brands, including strategic and programmatic approaches to regulatory compliance and pre- and post-breach cybersecurity governance and planning. He has deep experience preparing a variety of agreements for technology-driven transactions, with a focus on complex, high-value, and mission critical transactions for outsourced business processes, software development, licensing, hosting, software-as-a-service, cloud offerings, and complex technical implementations.
Theodore Sum, Partner, Smart & Biggar
Ted has broad IP expertise with an emphasis on licensing, commercialization and procurement, patent and trademark prosecution, due diligence, e-commerce, privacy and security. He’s often asked to counsel clients on IP strategy and advise them on the most effective methods to protect, manage and capitalize on their IP assets.
Known for his thoughtful, thorough and diligent approach, Ted works with clients across a wide range of sectors including high tech, software and IT, energy, clean tech, telecommunications, robotics, AI and machine learning, aerospace, defence, life science, chemicals, transportation, mining and forestry. In addition to his guidance during significant transactions, Ted advises clients on a broad range of IP matters involving the research, development, acquisition, clearance, commercialization and exploitation of products, technology and related intellectual property assets.
Alexander Sysoenko, Head of the DLT Development Center, Federal Institute of Industrial Property (FIPS) /RU PTO
Alexander Sysoenko is currently Head of DLT Development Center in the Federal Institute of Industrial Property of ROSPATENT (Russian PTO). He has more the 30 years of experience of fin-tech and art-tech projects with regional and federal governmental bodies.
He is taking part in the Committee of WIPO for Standards (Blockchain Task-Force) activities for exploring the possibility of using blockchain technology in the processes of providing IP rights protection, processing information about IP objects and their use.
Joseph Wing-On Tam, founder, secretary and president, Hong Kong Biochemistry Association
Dr. Joseph Wing On Tam received his Ph.D. in Chemistry, He was founder, secretary and president of the Hong Kong Biochemistry Association. Dr. Tam had been Visiting Professor at UCSF, BMC and Augusta College of Medicine and Universities in China; Visiting Scientist of NIH and R&D Director, EY Laboratories Inc. Honorary Assoc. Professor, HKU. Founder & Chairman, Pangenia Group.
Dr. Tam’s interests spread from protein to molecular biology, and has published in PNAS, Blood and other journals in genetic disease, DNA diagnosis, DNA fingerprinting and applied genomics. His laboratory in HKU embarked on rDNA technology in 1978 and he cloned the first human thalassemia recombinant libraries and in 1981 he introduced rDNA technology to train regional scientists in 1983. His laboratory has since cloned many genes, uncovered mutations including 2 of the 8 known beta-thalassaemia mutations among the Chinese. He is the inventor of many patents. The US patented Flow-Through DNA Hybridization Process is being applied in DNA macro and microarray development worldwide. Dr. Tam founded biotechnology companies namely HybriBio(??), DiagCor and Pangenia after retired from HKU in dedication to establish platform for the Hong Kong science graduates to work and excel. JTT is formed as a pre-angel investor, by investing in and advising early-stage startups in biotechnology and life science to help them build value to increase the odds of success.
Ozer Teitelbaum, Managing Director, Ocean Tomo, LLC
Ozer Teitelbaum has worked in the patent and licensing space for over 20 years in a variety of roles. He has drafted, developed and managed patents and portfolios for a varied list of clients. In addition, he has negotiated, drafted and prepared transactional agreements and managed globally distributed IP lawyers and licensing professionals.
Ozer worked at Alcatel-Lucent where he managed a six person IP team which formulated and implemented global IP strategies.
He currently works as a Managing Director or Ocean Tomo Investment Group, where he provides investment banking and advisory services to client including securitization of IP assets, capital raising, litigation financing, M&A activities, sale and purchase of business including trade secrets and patents, patent licensing and brokering IP assets and patent portfolios.
Ozer received a B.S. in Electrical Engineering from the Polytechnic Institute of New York University and a Juris Doctorate from the John Marshall Law School.
Ozer can be reached at 646-329-6618 and his email is email@example.com
Andy Topping, Chief Scientific Officer, FUJIFILM Diosynth Biotechnologies
Andy has worked in the biopharmaceutical industry for more than 25 years. Originally trained as a molecular biologist with a Ph.D. from the University of Wales in Cardiff, UK he has led development and manufacturing projects bringing over 100 proteins from microbial and mammalian expression systems into the clinic. He is Chief Scientific Officer for the CDMO Fujifilm Diosynth Biotechnologies, responsible for science and innovation across the company’s sites in Europe and the US. Fujifilm Diosynth Biotechnologies provides process and analytical development and manufacturing services to large Pharma and biotech customers to support their protein and gene therapy therapeutics.
Julie Turner, Partner Emerita, Turner Boyd LLP
Julie Turner became partner emerita in 2017, and now lives in Valencia, Spain. She represented both plaintiffs and defendants in intellectual property and commercial litigation matters over the course of her 20-year career. She litigated patent, copyright, trademark, and trade secret cases involving a wide range of electronics, software, consumer goods, and pharmaceutical technologies. She also represented clients in antitrust, First Amendment, defamation, contract, and business tort cases. Ms. Turner first-chaired ten trials without a defeat. Ms. Turner was named a “Super Lawyer” by Northern California Super Lawyers from 2009 to 2017.
Ms. Turner received her law degree in 1997 from U.C. Berkeley School of Law at the University of California at Berkeley. She graduated in the top 10% of her law school class and is a member of the Order of the Coif. While in law school, Ms. Turner was a member of the High Technology Law Review and the California Law Review, where she was elected to the executive committee. Ms. Turner received the American Jurisprudence Award in Constitutional Law and the Jurisprudence Award in Patent Law. Ms. Turner received her B.A. from Barnard College. Between college and law school, Ms. Turner worked in the area of international business and trade.
Before founding Turner Boyd LLP in 2008, Ms. Turner was a partner at Day Casebeer Madrid & Batchelder LLP, an associate at Cooley Godward LLP, and a solo practitioner.
Michele Tyrpak, Associate Director, University of South Florida
Michele is the Associate Director at the USF Tech Transfer Office and has over 20 years experience in all aspects of intellectual property law, including preparation and prosecution of global patent portfolios; IP transactional work, support of acquisition and divestiture efforts; and patent litigation support.
Michele previously worked as in-house patent counsel at the Lubrizol Corporation, and in various IP boutique law firms.
Sergey Vasiliev, Senior Lawyer, Gorodissky & Partners, Moscow
Sergey Vasiliev is a Senior Lawyer working in the Moscow office of the law firm “Gorodissky & Partners” (Russia). He specializes in various legal aspects related to protection, usage, licensing, litigation and enforcement of IP and IT assets in Russia and CIS. Sergey deals with various types of IP/IT, including copyrights and related rights, software and databases, patents and designs, trademarks, brands and domain names. He also deals with know-how and confidential information. Sergey helps national and international clients to develop the effective IP/IT enforcement strategies and provides legal advice on the robust defensive actions. He is a professional and experienced IP/IT litigator. He regularly represents domestic and foreign clients in front of local courts, administrative and other law enforcement agencies. Aside from dispute resolution, he advise clients on licensing and franchising as well as transactional issues. Sergey is an author of a number of publications. Member of Licensing Executives Society International (LESI) and other professional organizations.
Eric Victory, VP Global Strategic Marketing, Aurinia Pharmaceuticals
Eric is currently VP Global Strategic Marketing with Aurinia Pharmaceuticals, and he also serves as a board member for LES USA/Canada. He previously held roles in marketing, business development, and government project management for MedImmune and AstraZeneca. Prior to his time in the biopharmaceutical industry, Eric served as a commissioned officer in the US Navy Nuclear Propulsion Program.
Jay Vora, Senior Director of Alliance Management, Sangamo Therapeutics
Jay is responsible for managing multiple research and development partnerships at Sangamo Therapeutics. Previously, Jay established Program and Alliance Management function at REGENXBIO. Prior to that Jay served as Product Development Leader at Biogen for several clinical stage programs. In addition, as a management consultant with PRTM Management Consultants, Jay assisted several life sciences companies in design and execution of R&D strategies. Jay has a PhD in Pharmacokinetics from Northeastern University, Boston, and an MBA from University of California, Berkeley.
Keith Walker, Director, Intellectual Property Licensing, International Game Technology
Keith Walker brings international business development experience in intellectual property licensing, sales, valuation and strategy to the table. His deal experience includes licensing, divestiture and acquisition of patent portfolios; formulating and negotiating patent, trademark and software license agreements; royalty audit settlements; developing business cases supportug valuation and developing financial structures to close the deal.
Keith has worked as a corporate licensing executive with worldwide responsibility for IP licensing business. He has worked with International Game Technology, IBM, General Electric and the Eastman Kodak Company.
Keith received a B.S. in Management Information Systems/Computer Science from the University of Wyoming.
Brian Watson, Director, Wind River
Brian has over 10 years of technical experience providing a variety of global strategic, operational and organizational services around compliance and risk management. His experience includes building and managing global software compliance and asset management programs resulting in millions of dollars in revenue recovery and cost savings for his clients as a service provider. Today, Brian is the Director of Global License Compliance at Wind River.
Matthew Weinstein, Director, Legal - Patents and Open Source, Accenture
Matt Weinstein is Director, Legal – Patents and Open Source at Accenture. He counsels Accenture businesses on patent portfolio development and strategy, IP monetization, risk mitigation, dispute resolution, licensing and commercial contracting. He also manages and mentors Accenture’s open source legal team and provides leadership on all open source governance and licensing-related matters for the company.
Before joining Accenture in 2013, Mr Weinstein worked in private practice at Winston & Strawn LLP, where he represented leading technology and manufacturing companies in patent prosecution, litigation, opinion and IP transactional matters. He began his career as an IT consultant.
Mr Weinstein has a BS in computer engineering from the University of Maryland, College Park and a JD (magna cum laude) from the American University, Washington.
Emma Wheatley, Deputy GC, Head of Collaborations, Coalition for Epidemic Preparedness Innovations (CEPI)
Emma champions transformational change through action and has a particular interest in alliances between the public and private sectors in the biopharmaceutical industry. As Deputy General Counsel and Head of Collaborations at The Coalition for Epidemic Preparedness Innovations (CEPI), Emma has established the foundations for a leading edge alliance management structure for vaccine development against WHO priority pathogens with little or no market incentives. She has been busy in 2020 working to accelerate the development of and access to COVID-19 vaccines.
Prior to CEPI, Emma was VP Legal Affairs and Deputy General Counsel, at Emergent Biosolutions Inc leading legal strategy, teams and resources across operations in North America, Europe and Asia for a variety of vaccines, therapeutics and devices after forming a joint venture between Emergent and the University of Oxford for a TB vaccine. Whilst at Oxford University Innovation Ltd, she provided legal guidance on technology transfer licensing, equity investment and start-up formation for technology, vaccines, therapeutics and medical devices, as well as translational research. Her early legal career was spent in law firms in the UK advising a broad range of organisations with a sector focus on life sciences.
Emma has been admitted to the Bar in both England and Wales and New York State, USA.
Sam Wiley, Director, Global Business Intelligence Solutions, VALUENEX Inc.
Sam is an expert in applying intellectual property data to solve real business, technical, and legal problems. He recently joined VALUENEX, Inc, a Tokyo-based analytics firm that specializes in visually deriving insights from complex technical documents and data. He servers as the Secretary of the LES Valuation & Pricing Committee and is the income Vice-Chair of Memberships and Meetings for LES Young Members Congress.
Jin (”Victor”) Yang, Vice President/Group General Counsel, TCL Technology Group Corporation
Jin Yang (“Victor”) is the Chairman and CEO, Purplevine IP Group (Shenzhen) and Vice President and Group General Counsel, TCL Technology Group Corporation – a position he had held since July 2012.
Before this position, he held various corporate and legal positions including Chief Counsel, Alstom Power, Northeast Asia & China and General Manager of Beijing Spirit Consulting Co., Ltd., Co-founder and COO, Beijing Fudao.net Information Technology Co., Ltd. and associate in both the Beijing Tianyuan Law Firm and the King & Wood Law Firm. He has advanced degrees from the University of Cambridge (UK) and Beijing Foreign Affairs University.
Paul Zhang, Partner, BlueStar Bio
Paul is a senior leader in the life sciences consulting industry. He is a Partner at BlueStar Bio and was a Partner at Easton Associates LLC, a Managing Director at Navigant, which acquired Easton, and ClearView Healthcare Partners. He is also a preeminent expert on the rapidly evolving China market, having built a consulting team in Shanghai and Beijing over the last 10 years, advising clients on China market entry strategies and BD&L approaches.
Neil Zoltowski, Partner, StoneTurn
Neil Zoltowski serves as a consulting and testifying financial expert in complex business disputes, intellectual property litigation, and business and intellectual property valuation matters. Neil has more than 20 years of experience in the evaluation and quantification of economic damages in intellectual property disputes, including patent, copyright and trademark infringement, trade secret misappropriation, and false advertising and deceptive trade practices under the Lanham Act, as well as commercial disputes such as breach of contract, breach of fiduciary duty, unfair competition, stock valuation / shareholder disputes and diminution of business value claims. Neil also brings experience in IP and business valuation matters; has designed and executed compliance inspection programs and royalty audits; and has consulted with clients on licensing issues across a broad range of industries, including biotechnology, computer hardware and software, construction, consumer products and services, Internet and e-Commerce, electronics, insurance, life sciences, manufacturing, medical devices, and telecommunications, among others. Neil’s prior consulting experience includes several years at Deloitte, NERA Economic Consulting, and FTI Consulting. Neil holds the Certified Valuation Analyst and Master Analyst in Financial Forensics designations from the National Association of Certified Valuation Analysts, the Certified Licensing Professional designation from the Licensing Executives Society, and the Certified Patent Valuation Analyst from the Business Development Academy.